Updated List of Pigmentary genes
by: Laura L. Baxter, Lluís Montoliu, William J. Pavan and Stacie K. Loftus
Based on: Baxter, L. L., Watkins-Chow, D. E., Pavan, W. J., & Loftus, S. K. (2019). A curated gene list for expanding the horizons of pigmentation biology. Pigment cell & melanoma research, 32(3), 348–358. https://doi.org/10.1111/pcmr.12743
Current number of genes listed: 688
Last update: 8 December 2022 (previous update was 2 March 2021)
(*) Genomic duplications often result in paralogous genes; if paralogs were present that both show orthology to one of the other species listed here, then both are indicated. The alliancegenome.org links for each gene provide a detailed table describing the criteria used to determine orthologs across species.
The alliancegenome.org links associated with each gene provide a comprehensive resource of information, including: orthology, function - GO annotations, phenotypes, disease associations, alleles and variants, transgenic alleles, models, sequence feature viewer, expression and molecular interactions.
Human gene
|
Human paralog*
|
Mouse gene
|
Mouse paralog*
|
Zebrafish gene
|
Zebrafish paralog*
|
Human disease with hair and/or skin pigmentary phenotype (#OMIM)
|
Human pigmentation phenotype
|
Mouse pigmentation phenotype
|
Zebrafish pigmentation phenotype
|
Cell-based phenotype / other organism phenotype
|
|
|
|
Pigmentation disrupted | |||||||
|
|
|
Dyschromatosis universalis hereditaria 3
(#61402) |
Hyperpigmentation and hypopigmentation; symmetrical hyper- and hypopigmented macules that appear in infancy or early childhood on trunk, limbs, and face | Head melanocyte decreased amount | |||||
|
|
|
Pigment cell quality, abnormal; pigmentation arrested; reduced pigmentation in eye | |||||||
|
|
|
|
Hyperpigmentation, increased ear and skin and tail pigmentation, adrenocortical dysplasia (acd) | ||||||
ACTR3 | Actr3 | actr3b | Mice with a melanocyte-targeted ko of Actr3 (a.k.a. Arp3) show large white patches of fur on dorsal and ventral trunk as well as head, hypopigmentation of limbs and tail; hypopigmentation due to loss of melanocytes during development, PMID: 33028610 | Reduced expression of Actr3 in melanoblasts or primary melanocytes causes defective proliferation, migration, PMID: 33028610 | ||||||
|
|
Gray coat color; congenital graying in compound mutant of Bmpr2 (melanocyte-specific ko of Bmpr2) along with germline mutant of Acvr2a, Acvr2a+/-; Bmpr2flox/flox; K14-Cre (conditional), disorganized and clumping pigment present in hair medulla--smaller melanosomes that are still transferred to hair shaft, PMID: 22611050 | ||||||||
|
|
Reticulate acropigmentation of Kitamura
(#615537) |
Hyperpigmentation; reticulate macules on dorsa of hands and feet | Freckle-like macules occur in hairless mice that are heterozygous for the Pied mutation, which is a deletion in Adam10, PMID: 22834956 | ||||||
|
|
Irregular and dense pigmentation patterns within pelage hairs, altered hair follicle morphology | ||||||||
|
|
|
|
White spotting, belly spot, belted (bt) | ||||||
|
|
|
More reduced melanoblast number seen in Adamts20+/- mice or Adamts20-/- mice that were also haploinsufficient for Adamts9, as compared to Adamts20 mutation alone, PMID: 18454205 | |||||||
|
|
|
Dyschromatosis symmetrica hereditaria
(#127400) |
Hyperpigmented/hypopigmented macules (dorsum of hands and feet, face) | ||||||
|
|
|
Establishment of melanosome localization increased occurrence, abnormal | |||||||
|
|
|
Pigmentation process quality, abnormal; melanophore stripe broken | |||||||
|
|
|
Integument melanosome decreased amount; integument melanosome decreased pigmentation | |||||||
|
|
|
Hypopigmentation, hypopigmented feet and tail | |||||||
|
|
|
|
|
Hair graying in double KO with Afg3l2; Afg3l1 was whole animal null, while Afg3l2 was Tamoxifen-induced Cre-mediated targeting to oligodendrocyte lineage in adult mice (conditional); graying started ventrally, then spread dorsally | |||||
|
|
|
Hair graying in double KO with Afg3l1; Afg3l1 was whole animal null, while Afg3l2 was Tamoxifen-induced Cre-mediated targeting to oligodendrocyte lineage in adult mice (conditional); graying started ventrally, then spread dorsally | |||||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
Integument melanocyte decreased contractility, abnormal, integument melanocyte spatial pattern, abnormal | |||||||
|
|
Hyperpigmentation on footpads | ||||||||
|
|
|
Pigment cell decreased amount; whole organism pigmented, abnormal | |||||||
|
|
|
Pigmentation decreased occurrence, abnormal | |||||||
|
|
|
Rodent phenotype (Rhabdomys pumilio); developmentally regulates striping pattern | |||||||
|
|
ambra1a = pigmentation delayed / ambra1b = pigmentation delayed | ||||||||
|
|
|
Cell-based phenotype; Anxa2 KD reduces melanin content; BLOC-1-KIF13A-Annexin A2 molecular network regulates recycling endosome tubules, PMID: 26725201 | |||||||
AP1G1 | Ap1g1 | ap1g1 | KD of AP1G1 (gamma subunit of AP-1) results in decreased melanin production and melanosome biogenesis due to a malformation of endosomal carriers associated with a defect in TYRP1 trafficking to melanosomes. AP-1 complex interacts directly with KIF13A. PMID: 19841138 | |||||||
AP1M1 | Ap1m1 | ap1m1 | D of AP1M1 (mu subunit of AP-1) results in decreased melanin production and melanosome biogenesis due to a malformation of endosomal carriers associated with a defect in TYRP1 trafficking to melanosomes. AP-1 complex interacts directly with KIF13A. PMID: 19841138 | |||||||
|
|
|
Pigmentation decreased occurrence, abnormal | |||||||
|
|
HPS2, Hermansky-Pudlak syndrome 2
(#608233) |
Oculocutaneous albinism and fair hair | Diluted coat color, white spotting, hypopigmentation, abnormal skin pigmentation; decreased eye pigmentation, pearl (pe) | ||||||
|
|
|
HPS10, Hermansky-Pudlak syndrome 10
(#617050) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal retinal pigment epithelium, decreased eye pigmentation, mocha | |||||
|
|
|
Melanocyte decreased pigmentation | |||||||
|
|
|
Skin morphology alterations; Abnormal skin pigmentation, increased ear and forehead pigmentation, dark median line, delayed hair growth, abnormal keratinocyte differentiation, Apctm2Rak/Apctm2Rak; Tg(KRT14-cre)8Brn/0 (conditional) | |||||||
|
|
Diluted coat color, pale coat neuro | ||||||||
|
|
|
Melanosome transport decreased rate, abnormal | |||||||
|
|
|
Iridophore decreased amount; melanocyte decreased amount | |||||||
|
|
|
Diluted coat color, yellow coat color, decreased ear and tail pigmentation, agouti (a) | Melanocyte increased amount; melanophore stripe dorsalized, abnormal | ||||||
|
|
|
|
|
Trunk melanosome increased area, abnormal | |||||
|
|
|
Patches of red hair among black hair, 10% of surviving mice, Ate1tm1Avar/Ate1tm2.1Avar; Tg(CAG-cre/Esr1*)5Amc/0 (conditional) | |||||||
|
|
|
Hypopigmentation of the epidermis; Atg7 f/f; Tyr::Cre (conditional); Atg7 KO in melanocytes suppresses autophagy, melanin content of hair decreased by 10–15%, PMID: 25290687 | |||||||
|
|
|
Ataxia-telangiectasia
(#208900) |
Hyperpigmentation, cafe au lait spots | ||||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
|
Hypopigmentation, copper metallochaperone | |||||||
|
|
|
Melanocyte morphology, abnormal | |||||||
|
|
|
Melanocyte decreased pigmentation; melanocyte increased size, abnormal: melanosome organization process quality, abnormal: retinal pigmented epithelium melanosome decreased size, abnormal; retinal pigmented epithelium melanosome broken | |||||||
|
|
|
Whole organism unpigmented; pigment cell quality, abnormal; retinal pigmented epithelium disorganized | |||||||
|
|
|
Integument colorless; whole organism colorless; eye discolored | |||||||
|
|
|
Melanocyte decreased pigmentation; eye pigmentation disrupted | |||||||
|
|
|
Eye pigment granule organization process quality, abnormal; trunk decreased pigmentation | |||||||
|
Melanocyte decreased pigmentation; retinal pigmented epithelium quality, abnormal; trunk decreased pigmentation | |||||||||
|
|
|
Eye decreased pigmentation; trunk unpigmented | |||||||
|
|
|
Eye color, abnormal; melanocyte malformed; pigmentation decreased occurrence, abnormal | |||||||
|
|
|
Menkes disease
(#309400) |
Skin hypopigmentation and silvery hair, hair "steely" and "white" | Irregular coat pigmentation, absent coat pigmentation, copper transporter, mottled (Mo) | Pigmentation disrupted | ||||
|
|
|
|
Diluted coat color, hypopigmentation, toxic milk (tx) | ||||||
|
|
|
Hair graying, Atrtm1Bal/Atrtm2Bal; Ndor1Tg(UBC-cre/ERT2)1Ejb/0 (conditional) | |||||||
|
|
|
Darkened coat color, suppresses Agouti pigment type switching, mahogany (mg) | |||||||
|
|
|
Diluted, silver gray coat color, altered melanosome morphology in dermal melanocytes and RPE, functions to process PMEL, PMID:26912421, reduced melanin in hair shaft and uvea of eye, diluted (gray) coat color when treated with BACE inihibitor (inhibits BACE1 and BACE2), PMID: 23754390 | Melanocyte migration disrupted; melanocyte dilated, abnormal | ||||||
|
|
|
Hair follicle alterations; Abnormal coat/hair pigmentation, skin pigmentation, delay in the anterior to posterior clearing of pigments that occurs during the hair cycle | |||||||
|
|
|
Melanosome transport delayed, abnormal | |||||||
|
|
|
Melanosome transport delayed, abnormal; retina layer formation process quality, abnormal | |||||||
|
|
|
Melanosome transport delayed, abnormal; retinal pigmented epithelium ventral region absent | |||||||
|
|
|
Melanosome transport delayed, abnormal | |||||||
|
|
|
Melanosome transport delayed, abnormal | |||||||
|
|
|
Diluted coat color, gray coat color, hypopigmentation, irregular coat pigmentation | |||||||
|
|
|
Abnormal coat/hair pigmentation, graying hair, in combination with BCL2; PMID: 11709185 | |||||||
|
|
|
Heterozygous Becn1 mouse mutant shows hypopigmentation of coat; PMID: 19057677 | |||||||
|
|
|
Bloom syndrome
(#210900) |
Hypopigmented and hyperpigmented skin, sun-sensitivity, café au lait macules | ||||||
|
|
|
HPS8, Hermansky-Pudlak syndrome 8
(#614077) |
Hypopigmentation of skin and hair; retinal hypopigmentation | Diluted coat color, decreased ear and tail pigmentation, abnormal melanosome morphology, abnormal eye pigmentation, reduced pigmentation (rp) | |||||
|
|
|
Diluted coat color, abnormal melanosome morphology, decreased eye pigmentation, abnormal retinal pigmentation, cappuccino (cno) | |||||||
|
|
|
HPS11, Hermansky-Pudlak syndrome 11 | Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal melanosome morphology, decreased eye pigmentation, abnormal retinal pigmentation, hypopigmentation, muted (mu) | |||||
|
|
|
HPS9, Hermansky-Pudlak syndrome 9
(#614171) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal melanosome morphology, decreased eye pigmentation, ocular albinism | |||||
|
|
|
Melanocyte decreased amount | |||||||
|
|
PMID:22611050, Gray coat color; congenital graying in compound mutant of Bmpr2 (melanocyte-specific KO) with germline mutant with Acvr2a, Acvr2a+/-; Bmpr2flox/flox; K14-Cre (conditional); disorganized and clumping pigment present in hair medulla--smaller melanosomes that are still transferred to hair shaft | ||||||||
|
|
|
Melanocyte decreased amount; melanophore stripe malformed: trunk iridophore decreased amount; xanthophore decreased amount | |||||||
|
|
|
Melanocyte-specific KO shows premature graying after first hair cycle; PMID: 26440048 | |||||||
|
|
|
LEOPARD syndrome 3
(#613707) Cardiofaciocutaneous syndrome type 1 (#115150) |
LEOPARD syndrome = Pigmented lesions, lentigines, café au lait spots; Cardiofaciocutaneous syndrome = multiple lentigines | Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice, Braftm1Cpri/Braftm1Cpri; Tg(Tyr-cre/ERT2)1Lru/0 (conditional); also hair graying in mice with double knockout for Braf and Raf1 (c-raf), B-raff/f; C-raff/f; Tyr::Cre/°; Dct::LacZ/° or B-raff/f; C-raff/f; Tyr::Cre/°; Z/EG/° (conditional), PMID: 23022482 | |||||
|
|
|
|
Hair graying after gamma-irradiation, skin pigmentation defects | ||||||
|
|
|
Fanconia anemia FANCD1
(#605724) |
Hyperpigmentation, cafe au lait spots | ||||||
BRD9 | Brd9 | brd9 | KD inhibited melanin production in cultured melb-a mouse melanocytes, PMID: 36112085 | |||||||
|
|
|
Fanconia anemia FNACJ
(#609054) |
Hyperpigmentation, cafe au lait spots | ||||||
|
|
|
Abnormal coat/hair pigmentation, by day 14, Btd null mice fed a biotin-depleted diet exhibit whitening of the fur around the eyes and subsequent graying of the fur over the entire body | |||||||
|
|
|
Abnormal coat/hair pigmentation, irregular coat pigmentation, ventral coat is lighter resembling at or Aw; white feet and tail tip observed; yellow hair absent from ears, dense incisors (din) | |||||||
|
|
|
Melanosome transport delayed, abnormal | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Melanocyte pigment granule movement quality, abnormal; retinal pigmented epithelium pigment granule movement quality, abnormal | KD causes an increase in melanin production and the number of pigmented melanosomes associated with suboptimal melanin transfer in a coculture system and in human pigmented reconstructed epidermis. CAV1 contributes to mechanosignaling in skin melanocytes. PMID: 32532976 | ||||||
|
|
|
|
|
Pigmentation decreased occurrence, abnormal | |||||
|
|
|
Darkened coat color, abnormal foot pigmentation, increased ear pigmentation, increased tail pigmentation | |||||||
|
|
Homocystinuria
(#236200) |
Hypopigmentation of skin and hair | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
Melanosome transport disrupted, abnormal | |||||||
|
Melanosome transport disrupted, abnormal | |||||||||
|
|
|
PMID: 28238662,white spotting, extensive ventral white spotting, small patches of dorsal white spotting, hypopigmented paws and tail; Cdc42 f/f; Tyr::CreB+ (conditional) | Melanosome transport disrupted; melanocyte decreased amount, abnormal | ||||||
|
|
|
Melanocyte decreased amount, abnormal | |||||||
|
|
|
Pigment cell development disrupted | |||||||
|
|
|
Melanocyte differentiation delayed; eye pigmentation disrupted; axis melanoblast mislocalised medially | |||||||
|
|
|
|
Hypotrichosis with juvenile macular dystrophy (HJMD)
(#601553) ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEMS) (#225280) |
Retinal changes with prominent pigmentation in macular dystrophy, patients show unusually fair hair when compared to sibs | |||||
|
|
|
PMID: 29062096, diluted coat color, lighter brown coat color visible by 4 weeks (on C57Bl6 background), KD was from transgenic shRNA targeting Cdk5, polarized melanin distribution, at 8 weeks, sparse hair and skin plaques, thickened epidermis | |||||||
|
|
|
Abnormal coat/hair pigmentation, hair graying at 8 months of age in mice exposed to a tamoxifen diet from weaning, Cdk7Gt(D032B11)1.1Wrst/ Cdk7Gt(D032B11)1.1Wrst; Ndor1Tg(UBC-cre/ERT2)1Ejb/0 (conditional) | |||||||
|
|
|
Melanoma and neural system tumor syndrome
(#155755) |
Atypical and dysplastic nevi, susceptibility to cutaneous malignant melanoma | ||||||
|
|
White spotting, belly spot; PMID: 26952979, knockdown of function of all CDX family proteins by engrailed repressor spliced to CDX1; mice carrying additional KO of Cdx1 increases white spotting | ||||||||
|
|
|
Melanosome transport delay; PMID: 24550735 | |||||||
|
|
|
Melanosome transport decreased rate; whole organism decreased pigmentation | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Eye iridophore absent; whole organism melanocyte shape, abnormal; whole organism decreased pigmentation | Cell-based phenotype; regulates neural crest development/differentiation | ||||||
|
|
|
PMID: 23557358, deletion of Chek1 in melanocytes (Tyr::Cre transgene, conditional) showed complete absence of hair/skin pigmentation; melanoblasts specified at normal numbers, but lost to apoptosis starting at E12.5 | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Abnormal coat/hair pigmentation, early depigmentation and gray hair are present on top of the head and on the shoulders, at 48 weeks, mice exhibit premature fur depigmentation | |||||||
|
|
|
Cell-based phenotype; expression in B16 melanocytes increases pigment, PMID: 11434569 | |||||||
|
|
|
Hypopigmentation, organomegaly, and delayed myelination and development
(#618541)(2 patients) |
Cutaneous hypopigmentation, hypopigmented hair --note no osteopetrosis; PMID:31155284 | PMID: 24820037, gray fur in knockout on agouti background, also retinal degeneration; PMID: 31155284, gain-of-function mutation, hypopigmented fur, abnormal lysosomal storage, abnormal brain myelination, no osteopetrosis | |||||
CLEC12B | Clec12b | Cell-based phenotype; KD in normal phototype III/IV human melanocytes increases pigmentation, and overexpression reduces pigmentation; similar results seen in 3D skin culture models, PMID: 34896119 | ||||||||
|
|
Hair graying | ||||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
|
Whole organism decreased pigmentation | ||||||
|
|
|
Pigment cell spatial pattern, abnormal | |||||||
|
|
|
Belly spot | |||||||
|
|
|
Melanocyte melanosome absent | |||||||
|
|
|
Trunk melanosome absent | |||||||
|
|
|
Melanocyte melanosome absent | |||||||
|
|
|
Diluted coat color, mice exhibit a lighter coat color that is most pronounced in juveniles and persists through adulthood, many awl hairs are yellow instead of black | |||||||
|
|
|
Pigment cell decreased amount | |||||||
|
|
|
Melanocyte cellular pigment accumulation occurrence, abnormal; melanocyte cellular response to light intensity decreased occurrence, abnormal; melanocyte melanosome aggregated, abnormal | |||||||
|
|
|
Trunk iridophore decreased amount | |||||||
|
|
|
Melanocyte differentiation delayed; retinal pigmented epithelium poorly differentiated | |||||||
|
|
|
Melanocyte melanosome immature; melanocyte melanosome circular, abnormal | |||||||
|
|
|
Melanocyte melanosome aggregated, abnormal; melanosome localization disrupted | |||||||
CRTC3 | Crtc3 | crtc3 | Ctrc3 null mice show hypopigmented hair and skin; Mitf expression and melanogenic enzyme levels reduced, PMID: 34815795 | |||||||
|
|
|
Head xanthophore irregular spatial pattern: iridophore pigmentation process quality, abnormal: melanocyte decreased amount; melanophore stripe melanocyte decreased amount | |||||||
|
|
|
Hyperpigmentation of skin; keratinocyte-specific KO in Csnk1a1fl/fl; K14-Cre-ERT2 mice (conditional): p53-dependent, PMID: 28878021 | |||||||
|
|
|
Melanocyte increased amount, abnormal | |||||||
|
|
|
Cerebroretinal microangiopathy with calcifications and cysts-1 (CRMCC1)
(#612199) |
Graying hair; reticulated skin hyperpigmentation | ||||||
|
|
|
|
Immune-system related, variable depigmentation, 1 in 6 mice develop autoimmune vitiligo | ||||||
|
|
|
Abnormal melanoblast proliferation, white coat for loss-of-function in melanocytes, b-cateninfloxed/floxed; Tyr::Cre (conditional), gray coat for gain-of-function in melanocytes, activated b-catenin transgenic, PMID: 21862558, also, abnormal melanogenesis, Ctnnb1tm1Yy/Ctnnb1tm1Yy; Tg(Prrx1-cre)1Cjt/0 (conditional) | |||||||
|
|
|
Cystinosis
(#219800) |
Hypopigmentation of skin and hair; abnormal retinal pigmentation | ||||||
|
|
|
Melanocyte absent; pigmentation arrested | |||||||
|
|
|
Integument increased pigmentation; retina lacks all parts of type retinal pigmented epithelium microvillus | |||||||
|
|
|
Melanophore stripe melanocyte decreased amount, abnormal | |||||||
|
|
Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete
(#613743) |
Hyperpigmentation | |||||||
|
|
|
OCA8, Oculocutaneous albinism type 8 | Mild oculocutaneous albinism, hair hypopigmentation | Diluted coat color, abnormal iris color, slaty (slt) | |||||
|
|
|
Cell-based phenotype; regulates melanosome transport; KD causes melanosome dispersal to cell periphery, is a phenocopy of melanoregulin kd in ashen cells; phenocopy seen for KD of RILP, DCTN1 (aka p150Glued), and overexpression of DCTN2; PMID: 22275436 | |||||||
|
|
|
Cell-based phenotype; regulates melanosome transport; overexpression causes melanosome dispersal to cell periphery, is a phenocopy of melanoregulin kd in ashen cells; phenocopy seen for KD of RILP, DCTN1 (aka p150Glued), and overexpression of DCTN2; PMID: 22275436 | |||||||
|
|
|
Xeroderma pigmentosum XPE
(#278740) |
Pigmented or depigmented macules and patches | ||||||
|
|
Syndromic X-linked mental retardation of the Snijders Blok type (MRXSSB)
(#300958) |
Pigmentary skin anomalies | |||||||
DENND5A | Dennd5a | dennd5a |
|
Morpholino knockdown of dennd5a reduced pigmentation; a splice morpholino mimicing a human DENND5A mutation associated with familial melanoma showed reduced pigmentation and increased UV sensitivity, PMID: 34906508 | Cell-based phenotype; si knockdown decreased melanin levels and reduced dendricity, PMID: 34906508 | |||||
|
|
|
|
|
Melanocyte displaced to neural tube ventral surface, abnormal | |||||
|
|
|
Melanocyte irregular spatial pattern; xanthophore quality, abnormal | |||||||
|
|
|
Reduced pigmentation, reduced melanocyte number in body; PMID: 30840854 | |||||||
|
|
|
Developmental pigmentation delayed | |||||||
|
|
|
Pigmentation occurrence, abnormal | |||||||
|
|
|
X-linked dyskeratosis congenita (DKCX)
(#305000) |
Reticulated skin hyperpigmentation | ||||||
|
|
|
Pigmentation increased amount | |||||||
|
|
|
Melanocyte decreased amount; xanthoblast neural crest cell aggregated, abnormal | |||||||
|
|
|
Pigmentation disrupted | |||||||
|
|
|
Diluted coat color; belly spot; abnormal skin pigmentation; abnormal digit pigmentation; non-pigmented tail tip, misty (m), moonlight (mnlt) | |||||||
|
|
|
Darkened coat, hyperpigmentation, increased alpha-MSH levels | |||||||
|
|
|
|
Skin morphology alterations; Abnormal skin pigmentation, at 4-8 weeks of age, the skin is slightly darker in color, thick dermal layer, alopecia, lanceolate hair | ||||||
|
|
|
Spastic paraplegia 23
(#270750) |
Premature hair graying, café au lait spots, hypopigmentation of skin regions | ||||||
|
|
HPS7, Hermansky-Pudlak syndrome 7
(#614076) |
Oculocutaneous albinism and fair hair | Diluted coat color, decreased eye pigmentation, fewer melanosomes in RPE, sandy (sdy) | dtnbp1a = Melanin decreased amount, abnormal | |||||
|
|
|
Melanosome localization process quality, abnormal; melanocyte distended, abnormal; pigmentation process quality, abnormal | |||||||
DYNLT3 | Dynlt3 | dynlt3 | Cell-based phenotype; Dynlt3 kd reduces melanocyte movement, acidity/maturation, and transfer; regulated by b-catenin, PMID: 33772156 | |||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Pigment cell quality, abnormal; pigmentation delayed; whole organism decreased pigmentation | |||||||
|
|
|
Abnormal epidermal melanocyte morphology (dorsal skin melanocytes missing), abnormal choroid melanocyte morphology (melanocytes missing), abnormal harderian gland pigmentation (missing melanocytes) | |||||||
|
|
|
Iridophore decreased amount; melanocyte decreased pigmentation | |||||||
|
|
|
Abnormal hair follicle melanocyte morphology, irregular coat/hair pigmentation, abnormal skin pigmentation, transverse fur striping (missing agouti band leads to darker hair), tabby (Ta) | |||||||
|
|
|
Hair follicle alterations; Darkened coat color, reduced hairs with yellow banding in agouti mice, absence of the guard and zig-zag hairs, and presence abnormalities in intermediate hair types (awl and auchene), PMID: 17148670, downless (dl) | |||||||
|
|
|
Abnormal coat / hair pigmentation, abnormal skin pigmentation, copper-related, Agouti is modified-- the back is blacker, the flanks are yellower than normal, crinkled (cr) | |||||||
|
|
|
PMID: 27134165, transgenic mice with Edn1 expressed in keratinocytes, K14-rtTA; TetO-Edn1- lacZ, increased melanocyte stem cell proliferation and differentiation, also, when combined with Mc1R targeted KO in melanocytes (Tyr-CreER;Mc1Rfl/fl; K14-rtTA; tetO-Edn1-LacZ), showed rescue of wound healing melanocyte phenotype | |||||||
|
|
Waardenburg syndrome 4B
(#613265) |
Hypopigmented skin regions on face trunk and limbs; hypopigmented forelock, eyebrows, and eyelashes; premature graying; hypopigmented irides | Darkened coat color, abnormal ear pigmentation, abnormal skin pigmentation, abnormal melanosome morphology, lethal spotting (ls) | edn3b = melanocyte shape, abnormal; melanocyte decreased pigmentation | |||||
|
|
|
Waardenburg syndrome 4A
(#277580) ABCD syndrome (#600501) |
WS4A, hypopigmentation, hypopigmented skin patches, forelock, eyebrows, and eyelashes; Heterochromia irides; premature graying; ABCD syndrome; black lock, retinal depigmentation | Belly spot, head spot, white spotting, variable body spotting, abnormal choroid pigmentation, piebald | Iridophore absent; melanocyte absent; xanthophore spatial pattern, abnormal; trunk melanophore stripe malformed; trunk melanocyte decreased amount | ||||
|
|
|
Hair follicle alterations; Diluted coat color, hair follicle alterations, PMID: 26994968 | |||||||
|
|
|
Skin morphology alterations; Increased foot pad pigmentation, thick epidermis | |||||||
|
|
|
Cellular pigmentation decreased occurrence | |||||||
|
|
|
White spotting, belly spot, extra-toes spotting | |||||||
|
|
|
Melanocyte mislocalised; melanocyte decreased pigmentation | |||||||
|
|
|
Pigment cell quality, abnormal; pigmentation delayed; whole organism decreased pigmentation | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
Abnormal digit hyperpigmentation, hyperpigmented nail structures, abnormal hair follicle development | ||||||||
|
|
|
Cole disease
(#615522) |
Hypopigmentation, primarily on extremites; reduction in melanin content in keratinocytes | ||||||
|
|
|
Vici syndrome
(#242840) |
Hypopigmentation of skin and hair; cutaneous albinism, ocular albinism, retinal hypopigmentation | ||||||
|
|
|
Melanophore stripe irregular spatial pattern; melanocyte spatial pattern, abnormal; xanthophore decreased amount | |||||||
ERC1 | Erc1 | erc1a | erc1b | ERC1 (ELKS) KD resulted in reduced pigmentation and melanosome biogenesis. ERC1 (ELKS) is an effector of RAB6A. PMID: 28607494 | ||||||
|
|
|
Xeroderma pigmentosum XPD
(#278730) |
Pigmented or depigmented macules and patches | White spotting, hair graying with age | |||||
|
|
|
Xeroderma pigmentosum XPB
(#610651) |
Pigmented or depigmented macules and patches, freckling | ||||||
|
|
|
Xeroderma pigmentosum XPF
(#278760) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
Xeroderma pigmentosum XPG
(#278780) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
UV-sensitive syndrome-1 (UVSS1)
(#600630) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
Roberts syndrome, SC phocomelia syndrome
(#268300) |
Roberts syndrome, hyperpigmentation and hypopigmentation, café au lait spots, silvery blond hair; SC phocomelia syndrome, silvery blond hair | Integument decreased pigmentation | |||||
|
|
|
Head blaze, white spotting, belly spot, variable spotting | |||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
tlcd3ba = pigment cell decreased amount | ||||||||
|
|
|
Fanconia anemia FANCA
(#227650) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Fanconia anemia FANCC
(#227645) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Fanconia anemia FANCD2
(#227646) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Fanconia anemia FANCE
(#600901) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Fanconia anemia FANCI
(#609053) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
|
|
Melanocyte absent | |||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
|
Pigment cell irregular spatial pattern | |||||||
|
|
|
Crouzon syndrome with acanthosis nigricans
(#612247) |
Acanthosis nigricans, hyperpigmentation, hypopigmentation of surgical scars, melanocytic nevi | ||||||
|
|
Pigmentation decreased process quality, abnormal | ||||||||
|
|
|
Hypopigmentation, diluted coat color, pale tremor (plt) | |||||||
|
|
|
Terminal osseous dysplasia
(#300244) |
Pigmentary skin anomalies on face and scalp | ||||||
FMN1 | Fmn1 | fmn1 | No obvious pigmentation phenotype in KO mice. PMID: 19383632 | Fmn1 KD/KO in melanocytes induce melanosome clustering around the nucleus. FMN1 appears to be required for normal melanosome dispersion. PMID: 32661310 | ||||||
|
|
|
Prader-Wili-like form of Fragile X (FXS)
(#300624) |
Hyperpigmentation, periorbital, axillary, or genital | ||||||
|
|
|
Melanocyte decreased amount; iridophore decreased amount; melanophore irregular spatial pattern; xanthophore decreased amount | |||||||
|
|
|
Pigmentation delayed | |||||||
|
|
|
Skin morphology alterations; Reduced hair shaft melanin granule number; hairless and abnormal skin pigmentation; color oscillation across different regions becomes out of phase, ultimately resulting in evenly spaced bands of pigment that appear to travel across the body, nude (nu) | |||||||
|
|
Reduced pigmentation in vivo in response to forskolin; PMID: 29463842 | Cell-based phenotype; KD reduces pigmentation in cell cuture | |||||||
|
|
Variable body spotting | frem2a = melanocyte quality, abnormal | |||||||
|
|
PMID: 23633513, White belly spotting in KO mice | ||||||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Diluted coat color, light black (C57Bl6J background) or silver (agouti background) | |||||||
|
|
|
Pigmentation disrupted; melanocyte pigment granule decreased amount; xanthophore pigment granule decreased amount; retinal pigmented epithelium decreased pigmentation; iridophore pigment granule decreased amount | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
Skin morphology alterations; Abnormal hair follicle melanin granule morphology, abnormal epidermal layer morphology, Gata3tm3Gsv/ Gata3tm3Gsv; Tg(KRT14-cre)8Brn/0 (conditional), also Gata3jal/Gata3jal mice show abnormal epidermal layer morphology, abnormal hair shaft melanin granule distribution | |||||||
|
|
|
Head has fewer parts of type melanocyte | |||||||
|
|
|
Pigmentation process quality, abnormal; whole organism colorless | |||||||
|
|
|
|
Cell-based phenotype; GDF15 overexpression by fibroblasts induces melanin formation in human primary melanocytes, and KD reduces melanogenesis; PMID: 32416083 | ||||||
|
|
|
Pigment cell decreased amount | |||||||
|
|
|
Melanocyte decreased amount; melanocyte differentiation disrupted | |||||||
|
|
Diluted coat color, appear gray, dwarf grey | ||||||||
|
|
|
Iridophore pigmentation process quality, abnormal; melanophore stripe absent; whole organism dappled | |||||||
|
|
|
Iridophore pigmentation process quality, abnormal; melanocyte absent; melanophore stripe broken; pigmentation disrupted; xanthophore absent | |||||||
|
|
|
Belly spot, hypopigmentation, extra toes | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Iridophore pigment granule decreased amount: melanocyte pigment granule decreased amount; xanthophore pigment granule decreased amount | |||||||
|
|
Darkened coat color, increased ear pigmentation, increased foot pad and tail pigmentation, hyperpigmentation | ||||||||
|
|
|
Ocular albinism
(#139370) |
PMID:27607449, Ocular albinism; pigmentation abnormalities; hypopigmentation: affected males have subtly lighter hair and skin than their unaffected siblings | ||||||
|
|
|
Hyperpigmentation, darkened coat color, increased ear pigmentation, abnormal dermal pigmentation, Increased foot pad and tail pigmentation | |||||||
|
|
|
McCune-Albright syndrome
(#174800) |
Large cafe au lait spots | ||||||
|
|
|
Melanocyte morphology, abnormal | |||||||
|
|
|
Iridophore decreased amount; xanthophore decreased amount | |||||||
|
|
|
White spotting, belly spot | |||||||
|
|
|
Cell-based phenotype; hyperpigmentation, mediates estrogen steroid effects on human pigment synthesis; shown in vitro and in organotypic skin tissue; also agonists shown to have an effect in mouse ear, PMID: 2711534 | |||||||
|
|
|
Amyloidosis, primary localized cutaneous, 3 (PLCA3)
(#617920) |
Hyperpigmented and hypopigmented macules | Cell-based melanocyte phenotype; si-mediated KD causes reduced melanosomes | |||||
GNPTAB |
|
Gnptab |
|
gnptab |
|
Mouse transgenic model expressing a GNPTAB missense mutation associated with mucolipidosis type II and mucolipidosis type III alpha/beta showed reduced hair follicle pigmentation, PMID: 34116066 | In hair follicle organ cultures, GNPTAB kd reduced melanin production, melanosome sorting, and tyrosinase activity; KD in primary melanocytes also reduced melanin production and tyrosinase activity, and altered TYR protein sorting, PMID: 34116066 | |||
|
|
|
Ocular albinism, type I (OA1), Nettleship-Falls type
(#300500) |
Mild skin hypopigmentation; ocular albinism | Abnormal melanosome morphology, abnormal iris pigment epithelium, abnormal retinal pigment epithelium | Retinal pigmented epithelium melanosome decreased amount, retinal pigmented epithelium decreased pigmentation | ||||
|
|
Belly spot, PMID: 28135291; MOLF background increases belly spot incidence, vacuolated lens (vl) | ||||||||
|
|
|
Skin morphology alterations; Hypopigmentation, visible at 4 days, altered epidermal differentiation, Gpr89tm1.1Ymae/Gpr89tm1.1Ymae; Tg(KRT5-cre)1Tak/0 (conditional) | |||||||
|
|
|
Pigmentation disrupted | |||||||
|
|
Hyperpigmentation, Tg(Dct-Grm1)ESzc/0 (transgenic) | ||||||||
|
|
|
Belly spot | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
KD caused reduced melanocyte precursors, adult melanocyte number, and impaired adult melanocyte regeneration; PMID: 32098766 | Cell-based phenotype; KD reduced melanocyte precursors from mouse embryonic stem cells | |||||||
|
|
|
Melanocyte decreased amount; xanthoblast decreased amount | |||||||
|
|
|
Skin morphology alterations; Increased foot pad and tail pigmentation, epidermal hyperplasia Hdac1tm1.1Eno/Hdac1tm1.1Eno; Tg(KRT14-cre)1Ipc/0 | Pigment cell irregular spatial pattern | ||||||
|
|
|
|
PMID: 23792463, Hyperpigmentation, in combination with Hdac1 ko, Hdac1tm1.1Eno/Hdac1tm1.1Eno; Hdac2tm1.1Eno/Hdac2+, Tg(KRT14-cre)1Ipc/0 (conditional), greater hyperpigmentation in footpads than Hdac1 ko alone | ||||||
|
|
|
Abnormal coat/hair pigmentation, graying seen by P15 on agouti backgound | |||||||
|
|
|
PMID: 16651378, In mouse skin, suppresses graying/melanocyte apoptosis induced by DAPT; Dct-Hes1 transgenic | |||||||
|
|
|
Melanocyte amount ameliorated; suppresses melanoma | |||||||
|
|
|
|
Skin hyperpigmentation, 3 transgenic lines: HGFTg1, HGFTg43 and HGFTg75, hyperpigmentation of line 1 is light, of line 43 moderate and of line 75 dark, most analyses on line 43, PMID: 10842060 | ||||||
|
|
|
Melanocyte differentiation disrupted; eye decreased pigmentation | |||||||
|
|
|
Whole organism pigmentation, abnormal; pigment cell decreased amount | |||||||
|
|
hoxa13a = melanocyte disorganized, abnormal / hoxa13b = melanocyte disorganized, abnormal | ||||||||
|
|
|
Whole organism decreased pigmentation, abnormal | |||||||
|
|
|
HPS1, Hermansky-Pudlak syndrome 1
(#203300) |
Oculocutaneous albinism, hypopigmented hair, freckling and nevi | Decreased ear and tail pigmentation, decreased eye pigmentation, abnormal melanosome morphology, pale ear (ep) | |||||
|
|
|
HPS3, Hermansky-Pudlak syndrome 3
(#614072) |
Oculocutaneous albinism, hypopigmented hair; hypopigmentation of retina and choroid | Diluted coat color, decreased eye pigmentation, abnormal melanosome morphology, cocoa (coa) | |||||
|
|
|
HPS4, Hermansky-Pudlak syndrome 4
(#614073) |
Hypopigmentation of skin and hair, hypopigmentation of retina | Diluted coat color, decreased eye pigmentation, abnormal melanosome morphology, light-ear (le) | |||||
|
|
|
HPS5, Hermansky-Pudlak syndrome 5
(#614074) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal eye pigmentation, abnormal ear pigmentation, ruby-eye2 (ru2) | Iridophore absent; head melanocyte decreased amount; retinal pigmented epithelium decreased pigmentation; retinal pigmented epithelium melanosome decreased amount; retinal pigmented epithelium melanosome immature | ||||
|
|
|
HPS6, Hermansky-Pudlak syndrome 6
(#614075) |
Oculocutaneous albinism, hypopigmented hair | Diluted coat color, abnormal eye pigmentation, abnormal ear pigmentation, ruby-eye (ru) | |||||
|
|
Costello syndrome
(#218040) |
Hyperpigmentation, palmar nevi, congenital melanocytic nevi and blue nevi; also mutated melanocytic nevi | |||||||
|
|
|
Whole organism increased pigmentation | |||||||
|
|
|
PMID: 24024552, Hypopigmented hair in tamoxifen-induced, melanocyte-specific KO, Tyr-cre/ERT2-Hsp90b1flox/flox, (conditional) | |||||||
HTR2A | Htr2a | htr2aa | htr2ab | htr2aa knockout shows reduced response to 5-HT, PMID: 35682806 | Cell-based phenotype; pigmentation induced by 5-HT/seratonin is mediated by HTR2A, PMID: 35682806 | |||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigment accumulation delayed; trunk melanocyte disorganized | |||||||
|
|
|
KO mice show darkly pigmented dorsal skin and increased melanin content after 10-12 weeks; stems from oxidative damage and upregulated alpha-MSH expression in keratinocytes; PMID: 29660504 | |||||||
|
|
|
Mucopolysaccharidosis type II / Hunter syndrome
(#309900) |
Hyperpigmentation, mongolian spots, retinal pigmentation abnormalities | ||||||
|
|
|
Hurler syndrome
(#607014) |
Hyperpigmentation, mongolian spots | ||||||
|
|
|
Pigmentation delayed; whole organism decreased pigmentation | |||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Melanocyte absent, abnormal | |||||||
|
|
|
Melanocyte migration disrupted; melanophore stripe patchy | |||||||
|
|
|
|
Skin morphology alterations; Thickened and hyperpigmented skin, transgenic, Tg(KRT5-IKBKB)1Armz | ||||||
|
|
|
Incontinentia pigmenti
(#308300) |
Hypopigmented skin lesions, hyperpigmented macules in streaky configuration | Skin morphology alterations; Abnormal dermal and epidermal pigmentation, areas of reduced or absent pigmentation, lack of hair growth, increased keratinocyte apoptosis, abnormal kertinocyte morphology | |||||
|
|
|
|
Cell-based phenotype; IL-17 and TNF synergistically inhibited pigmentation-related signaling and melanin production; neutralization of TNF and IL-17 with mAbs resulted in a rapid recovery of pigment gene expression in psoriasis lesions, PMID: 29613836, IL-17 treatment of zebrafish skin inhibits melanogenesis, PMID: 23732752 | ||||||
|
|
|
Hair follicle alterations; Abnormal skin pigmentation, impaired hair follicle morphogenesis, Ilktm1Star/Ilktm1Star; Tg(KRT14-cre)1Amc/0 (conditional) | Pigment cell quality, abnormal | ||||||
|
|
|
Iridophore absent; xanthophore absent; head melanocyte increased amount, abnormal; pigmentation process quality, abnormal | |||||||
|
|
|
Whole organism pigmented, abnormal | |||||||
|
|
|
Melanosome localization disrupted | |||||||
|
|
|
Melanosome transport increased duration, abnormal; whole organism decreased pigmentation | |||||||
|
|
|
Melanosome transport affected; PMID: 18056639 | |||||||
|
|
Skin/hair/eye pigmentation, variation in, SHEP8
(#611724) |
Functionally regulates pigment variation regulation, cooperates with MITF to regulate expression of TYR | |||||||
|
|
|
Melanocyte melanosome increased distribution, abnormal | |||||||
|
|
|
Whole organism increased pigmentation | |||||||
|
|
|
Melanocyte irregular spatial pattern | |||||||
|
|
Skin morphology alterations; Abnormal skin pigmentation, abnormal dermal pigmentation, hypopigmentation, altered skin morphology described by publications, Itgb1tm1Ref/Itgb1tm1Ref; Tg(KRT5-cre)5132Jlj/0 (conditional) | ||||||||
|
|
|
Melanocyte decreased amount; melanophore stripe disorganized | |||||||
|
|
|
Cell-based phenotype; regulates human neural crest specification, knockdown inhibited differentiation of hESC-derived neural crest cells into progeny, including melanocytes | |||||||
|
|
|
Melanophore stripe irregular spatial pattern; melanophore stripe decreased amount; xanthophore spatial pattern, abnormal | |||||||
|
|
kctd15a and kctd15b double mutant = whole organism increased pigmentation, melanocyte increased amount, abnormal | ||||||||
|
|
|
Melanosome localization disrupted | |||||||
|
|
|
Melanocyte black, abnormal; melanocyte melanosome distended, abnormal; whole organism increased pigmentation | |||||||
|
|
|
Cell-based phenotype; si KD blocks melanosome maturation and reduces melanin content; PMID: 26725201 KD results in decreased melanin production and melanosome biogenesis due to a malformation of endosomal transporters associated with a defect in TYRP1 trafficking to melanosomes. KIF13A interacts directly with AP-1. PMID: 19841138 |
|||||||
|
|
Piebaldism
(#172800) |
White forelock; hypopigmentation of medial forehead, eyebrows, chin, ventral chest, abdomen, limbs; hyperpigmented borders of unpigmented areas; heterochromia irides | Absent coat pigmentation, diluted coat color, abnormal skin pigmentation, abnormal eye pigmentation, dominant spotting (W) | kita = melanoblast decreased amount; melanocyte decreased size; melanoblast transient increased amount, abnormal; melanocyte spatial pattern, abnormal; melanocyte apoptotic (many other melanocyte phenotypes) | |||||
|
|
|
Familial progressive hyperpigmentation with or without hypopigmentation
(#145250) |
Hyperpigmented and hypopigmented skin patches | Absent coat pigmentation, abnormal skin pigmentation, decreased tail pigmentation, abnormal eye pigmentation, steel (Sl) | Melanocyte decreased amount; melanocyte apoptotic; whole organism lacks all parts of type melanocyte | ||||
|
|
|
Hyperpigmentation; abnormal melanocyte morphology, melanocyte proliferation, increased melanoma incidence in ko mice; Krastm4Tyj/Kras+; Tg(Tyr-cre/ERT2)13Bos/0 (conditional) | |||||||
|
|
|
|
Skin morphology alterations; Hyperpigmentation, abnormal skin pigmentation, hyperkeratosis | ||||||
|
|
|
|
Skin morphology alterations; Increased pigmentation of ear, foot pad and tail, hyperkeratosis | ||||||
|
|
|
|
Skin morphology alterations; Diluted coat color, heterozygotes have a bright coat color apparent at 4 weeks of age, but less obvious at later time points, abnormal skin pigmentation, abnormal epithelial proliferation | ||||||
|
|
|
Dowling-Degos disease 1
(#179850) Epidermolysis bullosa simplex (#131800) |
Dowling-Degos disease 1, Progressive reticulate hyperpigmentation; Epidermolysis bullosa simplex, discrete 2 to 5-mm hyper- and hypopigmented macules, mottled pigmentation of the trunk and proximal extremities | ||||||
|
|
|
|
Skin morphology alterations; Hyperpigmentation on footpads, abnormal epidermis stratum spinosum morphology | ||||||
|
|
|
|
Naegeli-Franceschetti-Jadassohn syndrome
(#161000) Dermatopathia pigmentosa peticularis (#125595) |
Reticulate pattern of hyperpigmentation in both diseases | |||||
|
|
|
|
Hair follicle alterations; Abnormal hair follicle melanin granule morphology, hair follicle degeneration | ||||||
|
|
|
|
Hair follicle alterations; Abnormal hair shaft morphology, "both medulla and cortex have areas of dense pigmentation; where medullary structures break down, pigment aggregates on cortical ridges or is scattered" | ||||||
|
|
|
|
Skin morphology alterations; Integument, heavily pigmented and mildly to non-pigmented hair shafts have defects ranging from loose irregular aggregation of pigment, clumping of pigment within the medulla, clumping with focal distention of the shaft, segregation of pigment with a light brown colored medullary abnormality, to breaking of the hair in the middle of these deformities | ||||||
|
|
|
|
Skin morphology alterations; Increased foot pad and tail pigmentation, abnormal epidermal layer morphology | ||||||
|
|
|
Melanocyte amount, ameliorated | |||||||
|
|
|
Absent hair follicle melanin granule, PMID: 7958926; at P3, mutant hair follicles lack melanin granules, however, both epidermal and dermal melanocytes are present, suggesting melanin absence is secondary to arrest in hair follicle development | Melanocyte decreased amount; whole organism decreased pigmentation | ||||||
|
|
|
Head xanthophore decreased amount; head melanocyte decreased amount; trunk melanocyte decreased amount; trunk xanthophore decreased amount | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Eye degree of pigmentation, abnormal; whole organism increased pigmentation | |||||||
|
|
Hair follicle alterations; Abnormal hair shaft melanin granule, irregular melanin piles | ||||||||
|
|
|
Melanocyte dispersed, abnormal | |||||||
|
|
|
Skin morphology alterations; Abnormal epidermal melanocyte morphology, sparse and gray coat in hets, disheveled hair and ears | |||||||
|
|
|
Belly spot, white spotting, belt, dreher (dr) | |||||||
|
|
|
Pigment cell spatial pattern, abnormal | |||||||
|
|
|
OCA7, Oculocutaneous albinism 7
(#615179) |
Hypopigmentation of hair, skin, and irides, hypopigmented retina; freckling | Melanocyte migration disrupted; melanocyte decreased amount; epidermis blistered; whole organism decreased pigmentation | |||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Eye iridophore decreased amount; iridophore displaced to trunk; iridophore irregular spatial pattern; melanocyte decreased amount; melanophore stripe spotted, abnormal; trunk melanocyte decreased amount; trunk melanocyte mislocalised | |||||||
|
|
|
|
Cat mutation; darkened coat color, large blotches | ||||||
|
|
|
Chediak-Higashi syndrome
(#214500) |
Skin and hair hypopigmentation; iris hypopigmentation | Diluted coat color, decreased eye pigmentation, abnormal melanocyte morphology, beige (bg) | |||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Hypopigmentation, belly spot, dorsal hypopigmentation | |||||||
|
|
|
Cell-based phenotype; KD decreases melanogenesis; upregulates melanogenesis by increasing ERK-dependent MITF expression; autophagy-related, PMID: 26814135 | |||||||
|
|
|
Cell-based phenotype; increased melanosome transport in Xenopus cells; melanophore treatment with U0126 (inhibitor of the upstream ERK kinase MEK) prevented aggregation; also, constitutively active forms of Map2k1 increased aggregation; PMID: 15753041 | |||||||
|
|
|
Cell-based phenotype; increased melanosome transport; melanophores were treated with U0126, a potent inhibitor of the upstream ERK kinase known as MEK, & this prevented aggregation; also, constitutively active forms of Map2k2 increased aggregation, PMID: 15753041 | |||||||
|
|
|
Whole organism pigmented, abnormal | |||||||
|
|
|
Pigment cell spatial pattern, abnormal; pigmentation process quality, abnormal | |||||||
|
|
|
Eye decreased pigmentation; whole organism decreased pigmentation | |||||||
|
|
|
Abnormal coat/hair pigmentation, hypopigmentation, gray coat, woodrat | |||||||
|
|
|
Variation of Skin/hair/eye pigmentation 2
(#266300) Blond hair/fair skin, red hair/fair skin, also modifier of Albinism, oculocutaneous, type II |
Red hair/fair skin, blond hair/fair skin freckles | Abnormal melanogenesis, darkened coat, yellow coat color, recessive yellow (e) | Melanocyte dispersed, abnormal; pigmentation delayed, abnormal; melanocyte decreased amount | ||||
|
|
|
Glucocorticoid deficiency (GCCD1), due to ACTH unresponsiveness
(#202200) |
Hyperpigmentation of skin | ||||||
|
|
|
|
|
KO causes reduced melanin concentration for background color adaptation; PMID: 33301440 | |||||
|
|
|
Abnormal coat/hair pigmentation, slight graying sometimes observed in moribund animals | |||||||
|
|
|
Immunodeficiency-54
(#609981) |
Hyperpigmentation of skin | ||||||
|
|
Diluted coat color, belly spot, varitint waddler (Va) | ||||||||
|
|
|
Melanosome assembly "transport phenotype" delayed | |||||||
|
|
|
Increased foot pad and tail pigmentation | |||||||
|
|
|
Increased foot pad and tail pigmentation | |||||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
Pigment cell irregular spatial pattern, abnormal | |||||||
|
|
|
Melanocyte morphology, abnormal | |||||||
|
|
|
Melanocyte decreased amount; melanocyte decreased size | |||||||
|
|
Regulates melanocyte development, neural crest-specific knockout shows reduced melanocytes at birth, reduced melanosomes, Mef2cflox/–; Wnt1-CreTg/0 (conditional); PMID: 21610032 | ||||||||
|
|
|
Abnormal coat/hair pigmentation, alopecia, gray hair in tamoxifen-treated mice (ages 2 wk and 14 wk) Memo1tm1.1Neh/Memo1tm1.1Neh; Tg(CAG-cre/Esr1*)1Lbe/0 (conditional) | |||||||
|
|
|
Multiple endocrine neoplasia 1
(#131100) |
Cafe-au-lait macules, confetti-like hypopigmented macules | ||||||
|
|
|
Melanocyte decreased amount; melanocyte position, abnormal; trunk melanophore stripe malformed; xanthophore decreased amount; xanthophore spatial pattern, abnormal | |||||||
|
|
mepce = melanocyte amount, ameliorated | ||||||||
|
|
|
|
|
Quadruple mutant, mespaa, mespab, mespba, mespbb = larval melanophore stripe spatial pattern, abnormal, iridophore patchy, abnormal | |||||
|
|
|
|
|
Quadruple mutant, mespaa, mespab, mespba, mespbb = larval melanophore stripe spatial pattern, abnormal, iridophore patchy, abnormal | |||||
|
|
Quadruple mutant, mespaa, mespab, mespba, mespbb = larval melanophore stripe spatial pattern, abnormal, iridophore patchy, abnormal | ||||||||
MFN2 | Mfn2 | mfn2 | Cell-based phenotype; Mfn2 silencing increases pigmentation, melanogenic enzyme expression, and melanosome maturation, PMID: 35203350 | |||||||
|
|
|
Gray coat color, loss of pheomelanin band color, grizzled (gr) | |||||||
|
|
Darkened coat color, increased ear pigmentation, abnormal dermal pigmentation, increased foot pad and tail pigmentation, hyperpigmentation, mahoganoid (md) | ||||||||
|
|
|
Melanocyte irregular spatial pattern; trunk melanocyte absent | |||||||
|
|
Waardenburg syndrome type 2A
(#193510) Tietz albinism-deafness syndrome (#103500) |
Waardenburg syndrome 2A, congenital partial albinism on face, trunk, and limbs, hypopigmented forelock, eyebrows, and eyelashes; heterochromia irides; Tietz albinism-deafness syndrome, fair skin, white eyelashes, eyebrows, and white-blond hair | Absent coat pigmentation, white spotting, belly spot, abnormal eye pigmentation, microphthalmia (mi) | mitfa = eye iridophore absent; iridophore absent; melanocyte absent; pigment cell decreased amount; xanthophore decreased amount | |||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Diluted coat color with age, changing from black to "brighter" color (brownish) | |||||||
|
|
|
Diluted coat color | |||||||
|
|
|
Mismatch repair cancer syndrome
(#276300) |
Hyperpigmentation; cafe au lait spots; axillary freckling | ||||||
|
|
Griscelli syndrome 3 | Skin hypopigmentation; silver-gray hair | Diluted coat color, dark gray coat, leaden (ln) | mlpha = pigment granule dispersal arrested; melanocyte melanosome aggregated, abnormal | |||||
|
|
|
Melanocyte spatial pattern, abnormal | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Eye pigmentation disrupted; melanocyte differentiation delayed; retinal pigmented epithelium patchy | |||||||
|
|
|
Abnormal coat hair pigmentation, gray at 5 to 6 months, mitochondrial depletion syndrome | Eye iridophore decreased amount; integument translucent, abnormal; melanophore stripe morphology, abnormal; melanocyte decreased amount; pigment cell quality, abnormal | ||||||
|
|
|
Abnormal coat/hair pigmentation, pigment in hair follicles changes from black to light brown | |||||||
|
|
|
Glucocorticoid deficiency 2
(#607398) |
Hyperpigmentation of skin | ||||||
|
|
|
|
Suppresses pigment dilution phenotype, dilute suppressor | ||||||
|
|
|
Mismatch repair cancer syndrome 2 (MMRCS2)
(#619096) |
Hyperpigmentation; cafe au lait spots; axillary freckling | ||||||
|
|
|
Mismatch repair cancer syndrome 3 (MMRCS3)
(#619097) |
Hyperpigmentation; cafe au lait spots; axillary freckling | ||||||
|
|
|
Melanocyte decreased amount | |||||||
|
|
|
Belly spot, variable spotting, Myctm2Fwa/Myctm2Fwa; H2afvTg(Wnt1-cre)11Rth/0 (conditional) | |||||||
|
|
|
Pigmentation process quality, abnormal; xanthophore decreased pigmentation; xanthophore pigment granule condensed | |||||||
|
|
|
Pigmentation disrupted | |||||||
|
|
Griscelli syndrome 1
(#214450) |
Skin and hair hypopigmentation, silver-gray hair | Diluted coat color, dilute (d) | ||||||
|
|
|
In Snell's waltzer mice that do not express MYO6, choroidal melanocytes generate larger pigmented melanosomes. PMID: 22321127 | Cell-based phenotype; regulates actin dynamics, biogenesis of melanosomes; KD increases melanin in melanosomes; regulates delivery of Tyrp1, PMID: 22321127 MYO6 contributes to the generation of tubular carriers from pigmented melanosomes. KD causes increased melanin production in pigment cells associated with increased luminal acidity of pigmented melanosomes and suboptimal melanin transfer in a human coculture system. PMID: 29875258 |
||||||
|
|
|
White spotting | |||||||
|
|
|
Cell-based phenotype; in RPE cells, regulates melanosome motility; localizes to melanosomes; limited melanosome movement in wild-type RPE cells transduced with adenovirus carrying specific sequences to knockdown Myrip expression; part of Rab27a–Myrip–MyoVIIa complex, PMID: 11964381, PMID: 17451552 | |||||||
|
|
|
Belly spot, decreased tail pigmentation, PMID: 24721909 | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Nijmegen breakage syndrome
(#251260) |
Café au lait spots, hypopigmented spots | ||||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
NF1, neurofibromatosis type 1
(#162200) |
Cafe au lait spots and freckling | Increased ear, foot pad and tail pigmentation, decreased eye pigmentation | nf1a = lateral larval melanophore stripe melanocyte spatial pattern, abnormal / nf1b = lateral larval melanophore stripe melanocyte spatial pattern, abnormal | |||||
|
|
|
|
Cell-based phenotype in mouse mutant; knockout in hair follicle stem cells ectopic, differentiated melanocytes, but no hair graying b/c stem cells maintained | ||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency
(#614736) |
Hyperpigmentation of skin | C57BL/6J carrying Nnt mutation show lighter pigmentation compared to C57BL/6NJ mice with wt Nnt, PMID: 34233163 | Overexpression causes decreased melanocyte pigmentation; CRISPR-editing of nnt gene causes increased pigmentation, PMID: 34233163 | Darker pigmentation in Nnt siKD cells, redox-dependent and MITF-independent mechanism, PMID: 34233163 | |||
|
|
|
Melanocyte spatial pattern, abnormal | |||||||
|
|
Diluted coat color, dispersed gray hairs, in combination with Notch2, Notch1tm1Agt/Notch1tm1Agt; Tg(Tyr-cre)2Lru/0 (conditional) | ||||||||
|
|
|
Diluted coat color, dispersed gray hairs, more extensive in combination with Notch1, Notch2tm1Frad/Notch2tm1Frad; Tg(Tyr-cre)2Lru/0 (conditional) | |||||||
|
|
|
Melanocyte displaced to neural tube ventral surface, abnormal; melanocyte distended | |||||||
NPY | Npy | npy | Mouse model overexpressing NPY showed progressive hair graying as a result of McSC loss, PMID: 34114698 | |||||||
|
|
|
Adrenal hypoplasia congenita
(#300200) |
Adrenal insufficiency leading to hyperpigmentation | ||||||
|
|
|
Pigmentation delayed; whole organism increased pigmentation under visual background adaptation (VBA) assay | |||||||
|
|
|
Horse mutation; premature hair graying and melanoma susceptibility, may be combined effect of STX17 and NR4A3, or effect of one of these genes | |||||||
|
|
|
Melanocyte decreased amount; whole organism decreased pigmentation; trunk neural crest cell decreased amount | |||||||
|
|
|
Melanocytic nevus syndrome, congenital, somatic
(#137550) Neurocutaneous melanosis, somatic (#249400) |
Multiple, large, congenital melanocytic nevi | Hyperpigmentation, Nrastm1Tyj/Nrastm1Tyj; Tg(Tyr-cre/ERT2)1Lru/0 (conditional) | |||||
|
|
|
Skin morphology alterations; Irregular coat pigmentation, striped coat, hyperkeratotic plaques | |||||||
|
|
nsfa = melanocyte dispersed, abnormal / nsfb = retinal pigmented epithelium decreased pigmentation; whole organism decreased pigmentation | ||||||||
|
|
|
Abnormal coat/hair pigmentation, gray hair, abnormal skin pigmentation in tamoxifen-treated Nsmce2tm2.1Ofc/Nsmce2tm2.1Ofc; Ndor1Tg(UBC-cre/ERT2)1Ejb/0 (conditional), PMID: 26443207 | |||||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
Abnormal coat/hair pigmentation, abnormal retinal pigment epithleium morphology, hair growth looks delayed, older mice with white hair tips | |||||||
|
|
|
OCA2, Oculocutaneous Albinism Type II, Brown oculocutaneous albinism, regulates variation of Skin/hair/eye pigmentation 1, blond/brown hair, blue/nonblue eyes
(#203200) |
Hypopigmentation of skin, hair, irides | Diluted coat color, decreased eye pigmentation, pink-eyed dilution (p) | Melanocyte decreased amount; melanocyte melanosome decreased amount; melanocyte melanosome immature, abnormal; whole organism decreased pigmentation | ||||
|
|
|
Eye decreased pigmentation; melanocyte melanosome spatial pattern, abnormal; whole organism decreased pigmentation; melanosome localization disrupted | |||||||
|
|
|
Transverse fur striping, zigzag hairs are abnormally thin, slightly wavy, and have melanin clumps, wavy tiger | |||||||
|
Opn3 |
|
opn3 |
|
KD increases pigment in human epidermal melanocytes; overexpression decreases pigment in human melanoma cells, PMID: 31097585 | |||||
|
|
|
Pigment cell decreased perimeter, abnormal; pigment cell cell projection increased amount, abnormal | OPTN contributes to the generation of tubular carriers from pigmented melanosomes. KD causes suboptimal melanin transfer in a human coculture system. PMID: 29875258 | ||||||
|
|
|
Abnormal coat/hair pigmentation, agouti coat appears gray, grey-lethal (gl) | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Axis xanthoblast mislocalised medially; axis melanoblast mislocalised medially | |||||||
|
|
|
|
|
pigment cell quality, abnormal; whole organism decreased pigmentation | |||||
|
|
pafah1b1a = pigment cell morphology, abnormal / pafah1b1b = pigment cell morphology, abnormal | ||||||||
|
|
|
Phenylketonuria
(#261600) |
Hypopigmented skin and hair | Hypopigmentation, diluted coat color | |||||
|
|
|
Eye pigmented, abnormal; melanocyte pigment granule decreased amount; iridophore pigment granule decreased amount; xanthophore absent | |||||||
|
|
|
Melanocyte decreased amount; melanocyte neural crest cell migration process quality, abnormal; pigmentation decreased process quality, abnormal | |||||||
|
|
|
Fanconia anemia FANCN
(#610832) |
Hyperpigmentation; cafe au lait spots | ||||||
|
|
|
Cell-based phenotype; hypopigmentation, mediates progesterone steroid effects on human pigment synthesis; shown in vitro and in organotypic skin tissue, PMID: 27115344 | |||||||
|
|
Increased melanoma/metastasis formation (chemical induction with DMBA/TPA) | ||||||||
|
|
|
Dyskeratosis congenita DKCB6
(#616353) |
Abnormal skin pigmentation | ||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
Waardenburg syndrome 1
(#193500) Waardenburg syndrome 3 (#148820) |
Hypopigmented skin regions on face trunk and limbs; hypopigmented forelock, eyebrows, and eyelashes; premature graying; heterochromia irides; hypopigmented irides | Belly spotting, diluted coat color, absent skin pigmentation, splotch (Sp) | pax3a = xanthophore decreased amount; melanoblast decreased amount; melanocyte differentiation delayed; trunk melanocyte mislocalised | |||||
|
|
pax7a/pax7b double mutants = developmental pigmentation disrupted; development of xanthophores disrupted; increased melanophores in development and adults | ||||||||
|
|
|
Belly spot, hypopigmentation (10%) | |||||||
|
|
|
Reduction causes defects in melanoblast and melanocyte migration, PMID: 29604249 | |||||||
|
|
|
|
|
In pcdh10a ko, pcdh10b is upregulated; kd of both in melanocytes causes more severe melanocyte defects than in just pcdh10a alone, PMID: 29604249 | |||||
|
|
|
Microcephalic osteodysplastic primordial dwarfism type II
(#210720) |
Hyperpigmentation and hypopigmentation; café au lait spots | ||||||
|
|
|
Melanocyte melanosome spatial pattern, abnormal; melanocyte increased area, abnormal; cellular pigment accumulation arrested | |||||||
|
|
|
Abnormal agouti pigmentation, dark‐like (dal) | |||||||
|
|
|
Belly spot, white tail tip | |||||||
PI4K2A | Pi4k2a | pi4k2a | KD of PI4K2A resulted in the mistargeting of some melanogenic cargoes to melanosomes and is associated with decreased melanin production. Both PI4K2A and PI4K2b enzymes cooperate with BLOC-1 to produce endosomal tubules required for melanosome biogenesis. PMID: 36169639, 36169638 | |||||||
PI4K2B | Pi4k2b | pi4k2b | KD of PI4K2B resulted in the mistargeting of some melanogenic cargoes to melanosomes and is associated with decreased melanin production. Both PI4K2A and PI4K2b enzymes cooperate with BLOC-1 to produce endosomal tubules required for melanosome biogenesis. PMID: 36169639, 36169638 | |||||||
|
|
Diluted coat color, gray, Gt(ROSA)26Sortm1(cre/ERT2)Thl/0; Picalmtm1.1Tmae/Picalmtm1.1Tmae (conditional) | ||||||||
|
|
|
Melanocyte area, abnormal; melanocyte increased size, abnormal; pigmentation process quality, abnormal | |||||||
|
|
|
PMID: 29584722, coat color dilution, PIKfyveFlox/Flox; TyrCreERT2 (conditional), melanocyte-specific KO mice show graying (C57Bl6 background), regulates melanosome trafficking | |||||||
|
|
Melanocyte decreased amount, abnormal | ||||||||
|
|
|
Melanocyte spatial pattern, abnormal | |||||||
|
|
|
|
|
Xanthophore carotenoid vesicle aggregated, abnormal | |||||
|
|
|
Head melanocyte increased amount; cellular response of melanocyte constriction to light stimulus abnormal | |||||||
|
|
|
Belly spot, abnormal coat/hair pigmentation | |||||||
|
|
|
pmch expression changes in brain correlate with skin pigment levels; is a key regulator of food intake and energy homeostasis in mammals, but regulates pigment aggregation/coloration in teleosts (most ray-finned fish), PMID: 19827161, Overexpression causes impaired melanin concentration for background color adaptation, PMID: 33301440 | Cell-based phenotype; functions to modulate aMSH in human skin, PMID: 12176038 | ||||||
|
|
|
|
|
Overexpression causes impaired melanin concentration for background color adaptation, PMID: 33301440 | |||||
|
|
Abnormal tail pigmentation; abnormal choroid melanin granule morphology; abnormal retinal melanin granule morphology, silver (si) | pmela = melanocyte aggregated, abnormal; melanocyte decreased pigmentation; retinal pigmented epithelium melanosome decreased amount / pmelb = melanosome localization process quality, abnormal; retinal pigmented epithelium melanosome decreased amount | |||||||
|
|
|
Mismatch repair cancer syndrome 4 (MMRCS4)
(#619101) |
Hyperpigmentation; cafe au lait spots; axillary freckling | ||||||
|
|
|
Melanophore stripe decreased thickness; pigmentation disrupted | |||||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Dowling-Degos disease 2
(#615327) |
Reticular hyperpigmentation and hypopigmentation of the flexures | Whole organism axis decreased pigmentation | |||||
|
|
|
Dowling-Degos disease 4
(#615696) |
Hyperpigmentation; macular and lentiginous lesions; hyperpigmentation at rete ridges | ||||||
|
|
|
Melanocyte decreased amount, abnormal | |||||||
|
|
|
Pigmentary disorder, reticulate, with systemic manifestations, X-linked
(#301220) |
Reticulate skin hyperpigmentation | ||||||
|
|
|
Premature graying | |||||||
|
|
|
Xeroderma pigmentosum XPV
(#278750) |
Pigmented or depigmented macules and patches | Abnormal ear pigmentation upon UV exposure | |||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
Trunk decreased pigmentation | |||||||
|
|
Obesity, adrenal insufficiency, and red hair due to POMC deficiency
(#609734) |
Pale skin, red hair | Yellow coat color, diluted coat color | pomca = melanocyte melanosome aggregated, abnormal; melanosome localization disrupted | |||||
|
|
|
|
|
Hyperpigmentation with age for tails, paws and snout | |||||
|
|
|
Overexpression induces pigmentation in melanocyte-specific transgenic mice (darkens the fur of Ay/a mice) and also in cell culture, Tyr::rtTA; TetO::PGC-1α transgenics; PMID: 23201126 | |||||||
|
|
|
Pigment cell decreased amount | |||||||
|
|
|
Iridophore decreased pigmentation; melanocyte decreased pigmentation; melanocyte irregular spatial pattern; xanthophore decreased pigmentation | |||||||
|
|
|
KD of prickle2b suppresses bbs7 mutant-related melanosome transport delay; PMID: 24938409 | |||||||
|
|
Carney complex 1 (CNC1)
(#160980) |
Hyperpigmentation, profuse pigmented lesions, nevi, lentigines, ephelides | |||||||
|
|
|
Hyperpigmentation of footpad and tail | |||||||
|
|
prps1a = iridophore decreased amount; retinal pigmented epithelium decreased thickness; yolk iridophore decreased amount / prps1b = eye decreased pigmentation; eye iridophore decreased amount; yolk iridophore decreased amount | ||||||||
|
|
|
Trunk melanocyte decreased amount; melanocyte spatial pattern, abnormal | |||||||
|
|
|
Trunk melanocyte decreased amount; melanocyte spatial pattern, abnormal | |||||||
|
|
|
Acne inversa, familial, 2, with or without Dowling-Degos disease
(#613736) |
Reticulate hyperpigmentation in flexural areas, face, trunk, and neck | Pigment cell decreased amount | |||||
|
|
|
Belly spot | Pigment cell decreased amount | ||||||
|
|
|
Pigment cell decreased amount; retinal pigmented epithelium displaced, abnormal | |||||||
|
|
Bannayan-Riley-Ruvalcaba syndrome, Cowden syndrome
(#158350) |
Hyperpigmentation; lentigines, cafe au lait spots | Hyperpigmentation, Ptentm1Hwu/Ptentm1Hwu; Tg(Tyr-cre)1Lru/0 (conditional) | ||||||
|
|
|
Abnormal skin pigmentation, focal depigmentation secondary to immune system affects | |||||||
|
|
|
LEOPARD syndrome 1
(#151100) |
Multiple lentigines, cafe au lait spots, darkly pigmented spots | Abnormal melanocyte morphology, reduced number, Ptpn11tm1.1Wbm/ Ptpn11tm1.1Wbm; H2afvTg(Wnt1-cre)11Rth/0 (conditional) | Melanocyte decreased amount; melanocyte mislocalised | ||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Diluted coat color, light hair, and sparse hair | |||||||
|
|
|
Belly spot | |||||||
|
|
|
Cell-based phenotype; functional ablation induced perinuclear melanosome aggregation; long-range anterograde melanosome movements were suppressed in Rab1A-deficient melanocytes, PMID: 22854043 | |||||||
|
|
|
Melanosome transport decreased rate | |||||||
|
|
|
Cell-based phenotype; regulates TYRP1 trafficking and melanosome transport, PMID: 16965270; PMID: 21352276; is a lineage-specific melanoma driver, but no pigmentation correlation seen; PMID: 24981740 | |||||||
|
|
|
Injection of Rab8[T22N] mutation impacts melanosome transport time, PMID: 17574030 | |||||||
|
|
|
Cell-based phenotype; KD in melanocytes leads to loss of pigment; PMID: 26527546 | |||||||
|
|
|
Melanosome transport decreased rate | |||||||
|
|
|
Cell-based phenotype; mediates melanosome transfer to keratinocytes, siRNA reduces keratinocyte-stimulated melanin release from melanocytes; PMID: 24141907 | |||||||
|
|
|
|
Cell-based phenotype; Rab17 KD caused marked accumulation of melanosomes at the periphery, particularly in dendrites; also caused melanin accumulation, PMID: 21291502 | ||||||
|
|
Griscelli syndrome 2
(#607624) |
Skin hypopigmentation; silver-gray hair | Diluted coat color, abnormal melanosome transport, hypopigmentation, ashen (ash) | ||||||
|
|
|
Cell-based phenotype; knockdown in Rab38-deficient cht cells causes loss of pigmentation, thus Rab32 and Rab38 function together to regulate pigmentation and melanogenic enzyme trafficking; PMID: 17043139 | |||||||
|
|
|
Cell-based phenotype; regulates retrograde melanosome transport in melanocytes, PMID: 22740695 | |||||||
|
|
|
Diluted coat color, abnormal eye pigmentation, chocolate (cht) | |||||||
RAB3A | Rab3a | rab3aa | rab3ab | Cell-based phenotype; mediates melanosome release; stimulated by keratinocyte-conditioned medium, PMID: 36090299 | ||||||
RAB6A | Rab6a | rab6a | In conditional Tyr-specific KO mice, hypopigmentation of RPE and derived melanocyte culture. PMID: 28607494 | RAB6A KD resulted in reduced pigmentation and melanosome biogenesis associated with impaired trafficking of DCT and MART1 to maturing melanosomes. PMID: 28607494 | ||||||
RAB44 | Rab44 | rab44 | Regulates retrograde melanosome transport, PMID: 36126775 | |||||||
|
|
Diluted coat color, gunmetal (gm) | ||||||||
|
|
Skin morphology alterations; Abnormal skin pigmentation, white spotting, gray coat with progressive loss of hair, abnormal skin physiology, Rac1tm1Brak/ Rac1tm1Brak; Tg(KRT5-cre)5132Jlj/0 (conditional) | ||||||||
|
|
|
Belly spot, decreased foot and tail pigmentation | |||||||
|
|
|
Melanocyte mislocalised | |||||||
|
|
|
Hyperpigmentation, increased foot pad and tail pigmentation | |||||||
|
|
|
Iridophore decreased pigmentation; xanthophore decreased pigmentation | |||||||
|
|
Noonan syndrome 5
(#611553) |
Lentigines, café au lait spots | |||||||
|
|
|
Hypopigmentation of skin and hair, immune-related vitiligo after transplant of CD4-selected splenocytes | |||||||
|
|
|
Cell-based phenotype; in B16 melanoma cells, melanin production is inhibited in forskolin-stimulated cells; also inhibits dendrite formation & proliferation & promotes apoptosis; PMID: 16272156 | |||||||
|
|
|
Belly spot, decreased melanocyte cell number at E14.5, Raph1tm1.1Makr/Raph1tm1.1Makr; Tmem163Tg(ACTB-cre)2Mrt/0; Tg(Dct-LacZ)A12Jkn/ Tg(Dct-LacZ)A12Jkn (conditional) | |||||||
|
|
|
Melanosome localization disrupted; retinal pigmented epithelium quality, abnormal | |||||||
|
|
|
Abnormal melanocyte morphology, melanocyte growth defects, Rb1tm1.1Gfk/Rb1tm1.1Gfk; Tg(Tyr-cre)1Gfk/0 (conditional) | Melanocyte area, abnormal | ||||||
|
|
Diluted coat color, almost complete hair whitening interspersed with black hairs to produce gray coat, Rbpjtm1Hon/Rbpjtm1Hon; Tg(Tyr-cre)2Lru/0 (conditional) | ||||||||
|
|
|
Rothmund-Thomson syndrome type 2
(#268400) |
Premature hair graying, in context of premature aging | Skin morphology alterations; Absent coat pigmentation, patches of colorless hair in 65% of mice, alopecia with hair loss encompassing ~20% of body surface | |||||
|
|
|
Belly spot, Restfloxed/+; Wnt1-Cre (conditional); no belly spot seen in other conditional Cre alleles (P0-Cre, K14-Cre, Dct-Cre or Tyr-Cre), PMID: 25818501 | |||||||
|
|
|
Keratinocyte-specific KO increased pigmentation in mouse skin in response to UV and wound healing; PMID: 30046772 | |||||||
|
|
|
|
Hair follicle alterations; Abnormal hair shaft melanin granule; "A few tapered ends protrude only a short distance out of the hair shaft. The shafts generally lack hair cells and contain only irregular melanin granules," curly bare | ||||||
|
|
|
Melanocyte irregular spatial pattern; trunk melanocyte aggregated, abnormal; trunk decreased pigmentation | |||||||
|
|
|
Cell-based phenotype; regulates melanosome transport; KD is phenocopy of melanoregulin kd in ashen cells; melanoregulin regulates retrograde melanosome transport by interaction with the RILP–p150Glued complex in melanocytes--phenocopy seen for KD of RILP, DCTN1 (p150Glued), and overexpression of DCTN2, PMID: 22275436 | |||||||
|
|
|
Noonan Syndrome 8
(#615355) |
Hyperpigmentation | ||||||
|
|
|
Melanocyte increased branchiness; xanthophore decreased branchiness; xanthophore decreased size | |||||||
|
|
|
Melanocyte decreased amount | |||||||
|
|
rpgrb = pigment granule aggregation in cell center delayed, abnormal | ||||||||
|
|
|
Belly spot, white spotting, belly spot and tail (Bst) | |||||||
|
|
|
Hyperpigmentation of footpad, ear, and tail | |||||||
|
|
|
Belly spot, background sensitivity: white hairs on front legs that look like white stockings, Tail short (Ts) | |||||||
|
|
|
PMID: 18641651, Hyperpigmentation in keratinocyte-specific KO, Rps6lox/+; Tg.K5Cre/+ (conditional); hypopigmentation in melanocyte-specific KO, Rps6lox/+; Tg.MitfCre/+ (conditional) | |||||||
|
|
|
Belly spot, montu (Mtu) | |||||||
|
|
|
Pigmentation delayed | |||||||
|
|
|
Hyperpigmentation, abnormal skin pigmentation, increased foot pad and tail pigmentation | |||||||
|
|
|
Abnormal skin pigmentation, increased foot pad pigmentation, PMID: 18641651 | |||||||
|
|
|
Melanocyte melanosome decreased pigmentation | |||||||
|
|
|
Belly spot | |||||||
|
|
|
Hair follicle alterations; Diluted coat color, alopecia, premature graying, abnormal melanosome morphology, Rxratm2Ipc/Rxratm4Ipc; Tg(KRT14-cre)1Ipc/0 (conditional), also abnormal retinal pigmentation, Rxratm4Ipc/Rxratm4Ipc; Tg(Tyrp1-cre)1Ipc/0 (conditional) | |||||||
|
|
|
|
|
Mirage syndrome
(#617053) |
Hyperpigmentation, reflective of adrenal insufficiency | ||||
|
|
Dyschromatosis universalis hereditaria-1 (DUH1)
(#127500) |
PMID:25315659, PMID:26203640, PMID: 27659786, Hyperpigmentation and hypopigmentation; reticulate hypopigmentation and hyperpigmentation; hypo- and hyperpigmented macules; lentiginosis | |||||||
|
|
|
Melanocyte quality, abnormal; trunk decreased pigmentation | |||||||
|
|
|
|
|
Whole organism increased pigmentation | |||||
|
|
|
Melanocyte irregular spatial pattern; melanocyte morphology, abnormal | |||||||
|
|
|
Pigmentation decreased occurrence, abnormal | |||||||
|
|
|
Melanocyte differentiation disrupted, abnormal; melanocyte decreased amount, abnormal | |||||||
|
|
|
Whole organism degree of pigmentation, abnormal | |||||||
|
|
|
Belly spot | |||||||
|
|
|
Melanocyte differentiation disrupted | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
|
Fewer melanocytes in skin when sFRP4 protein overexpressed in mouse skin by adenovirus infection; sFRP4 normally secreted by keratinocytes, downregulates WNT signaling, prevents melanocyte differentiation, PMID: 28337220 | ||||||
|
|
|
Nephrotic syndrome 14
(#617575) |
Hyperpigmentation, reflective of adrenal insufficiency | ||||||
|
|
|
Cell-based phenotype; regulates trafficking of all 3 melanogenic enzymes; PMID: 26620560 | |||||||
|
|
Cell-based phenotype; si knockdown reduces melanin content, Tyr activity; show Sh3bp4 is directly upregulated by MITF and directly inhibited by miR-125B, PMID: 28819321 | ||||||||
|
|
|
Trunk melanocyte decreased amount | |||||||
|
|
|
Caudal fin melanocyte mislocalised | |||||||
|
|
|
Noonan-like syndrome with loose anagen hair 1
(#607721) |
Skin hyperpigmentation | ||||||
|
|
Xenopus mutation; cell-based melanocye phenotype showing regulation of melanosome biogenesis and localization, and RPE pigmentation defects | ||||||||
|
|
Darkened coat color, brown (agouti-like) hair on the dorsal region and slightly darker hair on ventral region when compared with Ay/a mice | ||||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
slc2a1a = whole organism decreased pigmentation, abnormal / slc2a1b = whole organism decreased pigmentation, abnormal | ||||||||
|
|
|
|
Xanthophore absent | ||||||
SLC7A5 | Slc7a5 | slc7a5 | SLC7A5 is a MITF-target gene. RNA-mediated knock-down of Slc7a5 or using a 2-amino-2-norbornanecarboxylic acid (BCH), an inhibitor of Slc7a5, in mouse B16F10 cells, human MNT1 melanoma cells and normal human melanocytes decreased pigmentation. PMID: 32240722 | |||||||
|
|
|
Diluted coat color, graying, yellow hair pigment is reduced, black pigment is unaffected, subtle gray (sut) | |||||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
|
Whole organism decreased pigmentation, abnormal | |||||||
|
|
|
Sialic acid storage disorder, infantile
(#269920) |
Hypopigmented skin and hair | ||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
Melanocyte quality, abnormal | |||||||
|
|
|
OCA6, Oculocutaneous albinism, type 6
(#113750) |
Hypopigmented skin, hair, irises | Abnormal coat/hair pigmentation, abnormal dermal pigmentation, abnormal iris pigmentation | Integument melanocyte decreased amount; melanocyte absent; cellular pigmentation process quality, abnormal; retinal pigmented epithelium unpigmented; melanophore stripe decreased; whole organism decreased pigmentation; melanocyte unpigmented | ||||
|
|
|
Histiocytosis-lymphadenopathy plus syndrome
(#602782) |
Skin hyperpigmentation, pigmented hypertrichosis | ||||||
|
|
|
Abnormal coat/hair pigmentation, portions of black, nonagouti hair can show bronzing effect, becoming reddish in patches, abnormal zinc homostasis, lethal-milk (lm) | |||||||
|
|
|
Hypopigmentation, Slc31a1tm2Djt/ Slc31a1tm2Djt, Tg(Vil1-cre)997Gum/0 (conditional), copper transporter | |||||||
|
|
|
Horse mutation; Champagne color, hypopigmentation, dilution of skin, hair, and eye, PMID: 18802473 | |||||||
|
|
|
Eye decreased pigmentation; trunk decreased pigmentation | |||||||
|
|
|
OCA4, Oculocutaneous albinism, type 4, coding region alterations affect variation of Skin/hair/eye pigmentation 5, black/nonblack hair, dark/fair skin, dark/light eyes
(#606574) |
Hypopigmented skin, hair, irides | Abnormal skin pigmentation, hypopigmentation, diluted coat color, abnormal eye pigmentation | Melanocyte decreased pigmentation; melanocyte absent; melanocyte decreased pigmentation; retinal pigmented epithelium unpigmented, abnormal; whole organism colorless; whole organism decreased pigmentation | ||||
|
|
|
PMID: 28431046, white spotting, Smarca4 Mos6/+; Sox10 LacZ/+ double heterozygous mice show synergistic increase in white spotting, also neural crest-specific KO causes melanoblast reduction Smarca4tm1.2Pcn; Tg(SOX10-cre)1Wdr (conditional) | Melanocyte decreased amount; retinal pigmented epithelium decreased pigmentation; whole organism decreased pigmentation | ||||||
|
|
|
PMID: 15890782, PMID: 17450140, heterozygous Smarca5 mutation causes dominant mottled coat with in mice with variegated allele of a, Avy/a, paternal effect, study measuring epigenetic changes/methylation | |||||||
|
|
|
Schimke immunoosseous dysplasia
(#242900) |
Hyperpigmentation, numerous lentigines | ||||||
|
|
|
Melanocyte decreased amount | |||||||
|
|
|
PMID: 15890782, PMID: 18425126, study measuring epigenetic changes at variegated allele of a, Avy, affects percentage of female yellow pups on Avy background, X-inactivation role | |||||||
|
|
|
Curry-Jones syndrome
(#601707) |
Hypopigmented streaky lesions | Caudal fin melanocyte mislocalised | |||||
|
|
|
|
|
Melanosome aggregation; recombinant protein induced melanosome aggregation in a concentration-dependent manner; PMID: 16259984 | |||||
|
|
|
Waardenburg Syndrome 2D
(#608890) Piebaldism (#172800) |
Hypopigmented skin regions on face, trunk and limbs; hypopigmented forelock, eyebrows, and eyelashes; hyperpigmented borders of hypopigmented areas; premature graying; heterochromia iridis | Head blaze, variable body spotting | |||||
|
|
|
Pigmentation disrupted | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
PMID: 35858560, Sox2 regulates pigment switching to govern pheomelanin vs. eumelanin production; Sox2 also regulates BMP signaling to govern eumelanin production; Previous inconsistent data: PMID: 15846349, Ysb mutation (complex chromosomal rearrangement caused by transgene insertion upstream of Sox2) was crossed with a Sox2 targeted null; "Similar to Ysb/Ysb and Lcc/Lcc mutants, Ysb/Sox2bgeo compound heterozygotes exhibited yellow coats as well as circling and deafness, indicating non-complementation;" Conversely, PMID: 22186729, Sox2fl/fl; Wnt1Cre mice (conditional) showed increased embryonic melanoblast numbers, but at postnatal (P)5 "revealed no increase in skin color and melanocyte numbers in hair follicles of the back skin" | |||||||
|
|
|
Medaka mutation; melanocyte phenotype, fate switch in pigment cell development, PMID: 24699463 | |||||||
|
|
Diluted coat color, white spotting, Tg(Dct-SOX9)aCeb, transgenic (two lines generated) | sox9a = iridophore decreased amount; melanocyte increased size, abnormal / sox9b = iridophore decreased amount; melanocyte increased size, abnormal | |||||||
|
|
|
Waardenburg syndrome 2E
(#611584) Waardenburg syndrome 4C (#613266) PCWH syndrome (#609136) |
All 3 syndromes show hypopigmented skin regions; hypopigmented forelock, eyebrows, and eyelashes; premature graying, heterochromia irides; bright blue irides; WS2E also reports cafe au lait spots; freckling | Belly spot, diluted coat color, decreased foot and tail pigmentation | Melanocyte decreased amount; pigment cell irregular spatial pattern; xanthophore morphology, abnormal | ||||
|
|
|
Darkened coat color, reduced subapical pheomelanin band | |||||||
|
|
|
Diluted coat color, pale skin | |||||||
SPIRE1 | Spire1 | spire1a | No obvious pigmentation phenotype in KO mice. PMID: 24345451 | Spire1 KD/KO in melanocytes induce melanosome clustering around the nucleus. SPIRE1 appears to be required for normal melanosome dispersion. PMID: 32661310 | ||||||
SPIRE2 | Spire2 | spire2 | No obvious pigmentation phenotype in KO mice. IMPC | Spire2 KD/KO in melanocytes induce melanosome clustering around the nucleus. SPIRE2 appears to be required for normal melanosome dispersion. PMID: 32661310 | ||||||
|
|
|
Legius syndrome
(#611431) |
Cafe-au-lait spots, axillary freckling | ||||||
|
|
|
Diluted coat color, varies on genetic background | |||||||
|
|
|
Integument pigmentation disrupted; melanophore stripe decreased width; melanophore stripe patchy; integument xanthophore mislocalised | |||||||
|
|
|
Salt and pepper developmental regression syndrome
(#609056) |
Hyperpigmented 2 to 5-mm macules mainly on the extremities, 'salt and pepper' pigmentary changes | ||||||
|
|
|
Lipoid adrenal hyperplasia
(#201710) |
Congenital hyperpigmentation, from intrauterine glucocorticoid deficiency | ||||||
|
|
stim1a = PMID: 29311116, KD reduces melanin content and melanophore pigmentation (melanoblast and melanophore number/location normal) / stim1b = no influence pigmentation | Cell-based phenotype; regulates melanin production; stim1b shown not to influence pigmentation, PMID: 29311116 | |||||||
|
|
|
Peutz-Jeghers syndrome
(#175200) |
Hyperpigmented spots on hands (especially palms), arms, feet (especially plantar areas), legs, and lips | ||||||
|
|
|
Cell-based phenotype; Stx3 regulates melanosomal localization of TYRP1, and KD reduces melanin content; PMID: 23549422 | |||||||
|
|
|
Cell-based phenotype; kd reduces pigmentation of melanocytes in vitro; interacts with VAMP7; regulates cargo delivery from recycling endosomes during melanosome biogenesis, PMID: 26208634 | |||||||
|
|
|
Horse mutation; gray phenotype is caused by a 4.6-kb duplication in intron 6 of STX17; both STX17 and the neighboring NR4A3 gene are overexpressed in melanomas from Gray horses; phenotypes in Gray horses may be caused by overexpression of both STX17 and NR4A3, or of one of these alone, PMID: 18641652 | |||||||
|
|
stxbp1a = whole organism increased pigmentation / stxbp1b = whole organism increased pigmentation | ||||||||
|
|
|
Darkened coat on agouti background, increased pigmentation of tail and paws, ventral alopecia | |||||||
|
|
|
Lateral larval melanophore stripe has fewer parts of type melanocyte | |||||||
|
|
|
Melanocyte decreased amount; whole organism decreased pigmentation | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
Cell-based phenotype; binds RAb27a, required for peripheral melanosome distribution and elongated cell shape in melanocytes; slp2-a = Sytl2 | ||||||||
|
|
|
Diluted coat color | |||||||
|
|
|
Grizzled coat color | |||||||
|
|
|
Melanocyte growth defects, Taf4tm1Idvd/Taf4tm1Idvd; Tg(KRT14-cre/ERT2)1Ipc/0 (conditional) mice show "invasive melanocytic tumors" upon treatment with the mutagen DMBA, PMID: 17626060 | |||||||
|
|
|
Cell-based phenotype; functions as GTPase activating protein for Rab27a and induces melanosome aggregation in mouse melanocytes | |||||||
|
|
|
Cell-based phenotype; functions as GTPase activating protein for Rab27a and induces melanosome aggregation in mouse melanocytes | |||||||
|
|
|
Whole organism degree of pigmentation, abnormal | |||||||
|
|
|
Hypopigmentation, head spot, Dancer (Dc) | |||||||
|
|
|
Abnormal ventral coat pigmentation, "in combination with at and Aw, lighter belly hair comes up farther on the sides and face than patterning of at or Aw", PMID: 14737183, droopy ear (de) mutant | |||||||
|
|
|
Hypopigmentation, abnormal ventral coat pigmentation, yellow ventrum pigmentation, instead of light gray pigmentation in controls | |||||||
|
|
|
Pigment accumulation process quality, abnormal | |||||||
|
|
|
Skin morphology alterations; Hyperpigmentation, Terf1tm1.1Blas/Terf1tm1.1Blas; Tg(KRT5-cre)1Tak/0 | |||||||
|
|
|
K5-Terf2 transgenic, PubMed:16142233, hyperpigmented skin in sun-exposed areas | |||||||
|
|
|
Hyperpigmentation, Terf2iptm1.1Blas/Terf2iptm1.1Blas; Tg(KRT5-cre)1Tak/0 (conditional) | |||||||
|
|
|
Dyskeratosis congenita DKCA2
(#613989) |
Graying hair; reticulated skin hyperpigmentation | ||||||
|
|
|
Pigmentation process quality, abnormal, in combination with tet3 | |||||||
|
|
|
Pigmentation process quality, abnormal, in combination with tet2 | |||||||
|
|
|
Belly spot, abnormal foot and tail pigmentation, Tfap2atm1Hsv/ Tfap2atm2Will; H2afvTg(Wnt1-cre)11Rth/0 (conditional), also abnormal retinal pigment epithelium, Tfap2atm1Will/ Tfap2atm1Will | Melanocyte absent; melanocyte differentiation disrupted; melanocyte pigment granule decreased amount; pigmentation disrupted; retinal pigmented epithelium mislocalised | ||||||
|
|
|
Melanocyte absent | |||||||
|
|
|
Melanocyte differentiation disrupted; melanocyte pigment granule decreased amount | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
PMID: 20144786, Graying in mice with melanocyte-specific KO, TGFBRIIfx/fx; Dctcre/cre mice (conditional), ectopic pigmented melanocytes with dendritic morphology | ||||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Dyskeratosis congenita DKCA3
(#613990) |
Graying hair; reticulated skin hyperpigmentation | ||||||
|
|
|
Iridophore structure, abnormal; melanocyte decreased amount; melanophore stripe broken; xanthophore displaced to melanophore stripe | |||||||
|
|
|
Autoinhibition-defective Tln1 mutant mice show belly spots (reduced ventral follicular melanocytes), hypopigmented tail tips and feet; primary mutant melanocytes show greater adhesion, less migration; PMID: 32580934 | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Darkened coat color, abnormal digit and footpad pigmentation, increased tail pigmentation | Pigmentation sporadic, abnormal | ||||||
|
|
|
ADULT syndrome
(#103285) |
Hypopigmentation of skin and hair, and hyperpigmentation, intense freckling | ||||||
|
|
|
Coding region alterations affect variation of skin/hair/eye pigmentation 10, blond/brown hair
(#612267) |
Blond/brown hair | Eye decreased pigmentation; trunk decreased pigmentation | |||||
|
|
|
Skin morphology alterations; Abnormal skin pigmentation, lighter skin color at birth, with gradual pigmentation, alopecia, Traf6tm1Jino/ Traf6tm1Jino | |||||||
|
|
|
|
Irregular coat pigmentation, abnormal melanosome morphology, abnormal retinal pigmentation | ||||||
|
|
|
Melanosome transport delayed | |||||||
|
|
|
Iridophore degree of pigmentation, abnormal; iridophore increased amount; iridophore irregular spatial pattern | |||||||
|
|
|
Horse mutant; white spotting and blindness, differential expression in retina and pigmented/unpigmented skin of appaloosa horses; no human dermal pigment phenotype, but causes congenital stationary night blindness | |||||||
|
|
|
PMID: 22203997, hypopigmentation; white hair due to missing melanoblasts/melanocytes seen in neural crest-specific knockout, Trpm7fl/fl; Pax3-Cre (conditional) | Melanocyte colorless; melanocyte differentiation disrupted; melanocyte irregular spatial pattern; melanocyte melanosome malformed | ||||||
|
|
Tuberous sclerosis complex 1
(#191100) |
Hypopigmentation, hypomelanotic macules | |||||||
|
|
|
Tuberous sclerosis complex 2
(#613254) |
Hypopigmentation, hypomelanotic macules | ||||||
|
|
|
In mutation causing constitutive tshr activation, melanocyte decreased amount; xanthophore increased amount; xanthophore differentiation abnormal / in hypomorphic allele, opposite observed (increased melanocytes, decreased xanthophores) | |||||||
|
|
|
|
|
Melanophore stripe irregular spatial pattern; melanocyte decreased cellular motility; melanocyte confluent with xanthophore | |||||
|
|
|
pigmentation disrupted; eye lighter in figure image | |||||||
|
|
|
|
|
Melanocyte quality, abnormal; pigment cell irregular spatial pattern; pigment cell decreased amount | |||||
TXNRD1 | Txnrd1 | Melanocyte-specific knockout model (Txnrd1mel -/-) shows ventral spotting, hypopigmentation of tail, ears, and paws, and increased sensitivity to UV irradiation, PMID: 35031135 | ||||||||
|
|
|
Melanocyte quality, abnormal; retinal pigmented epithelium quality, abnormal | |||||||
|
|
|
OCA1A, Oculocutaneous albinism, type IA
(#203100) OCA1B, Oculocutaneous albinism type IB (#606952) coding region alterations affect variation of skin/hair/eye pigmentation 3, blue/green eyes, light/dark/freckling skin |
Absence of skin, hair, and iris pigmentation | Absent coat pigmentation, diluted coat pigmentation, abnormal eye pigmentation, albino (c) | Iridophore morphology, abnormal; melanocyte decreased pigmentation; retinal pigmented epithelium melanosome absent | ||||
|
|
OCA3, Oculocutanous albinism, type III, coding region alterations affect variation of skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)
(#203290) |
Hypopigmented skin, hair, and irides, in some dark-skinned individuals, bright copper-red coloration of skin and hair and dilution of iris pigmentation | Diluted coat color, abnormal iris pigmentation, decreased eye pigmentation, brown (b) | tyrp1a = melanocyte colorless; retinal pigmented epithelium brown, abnormal; melanocyte melanosome decreased amount / tyrp1b = dermis melanocyte decreased size, abnormal; melanocyte brown, abnormal; retinal pigmented epithelium brown, abnormal | |||||
|
|
|
Melanophore stripe disorganized; melanocyte differentiation delayed | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Abnormal dorsoventral coat patterning, dorsal coat darkens from brown to "black hair" and then turns to gray with age | |||||||
|
|
|
Pigmentation process quality, abnormal | |||||||
|
|
|
Abnormal ventral coat pigmentation, 10% of homozygotes have belly spot | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Mental retardation, X-linked 99, syndromic, female-restricted
(#300919) |
Skin pigmentary abnormalities following the lines of Blaschko | ||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Pigmentation decreased occurrence | |||||||
|
|
|
Morphilno kd causes reduced pigmented melanocytes; PMID: 30061422 | Cell-based phenotype; KO causes hypopigmentation and melanosome mislocalization in cultured B16 cells, stable overexpression causes hyperpigmentation | ||||||
|
|
|
UV-sensitive syndrome 3 (UVSS3)
(#614640) |
Freckling and modest pigmentation anomalies, Xeroderma pigmentosum-like symptoms | ||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Diluted coat color | |||||||
|
|
|
Cell-based phenotype; kd reduces pigmentation of melanocytes in vitro; interacts with STX12; regulated by BLOC-1 and BLOC-3 and cycles to and from melanosomes to aid in trafficking and secretion of pigment enzymes, PMID: 27482051, PMID: 26208634 | |||||||
|
|
|
Hyperpigmented paws; PMID: 25340873 | |||||||
VDAC1 |
|
Vdac1 |
|
vdac1 |
|
Vdac1 knockout mouse shows upregulated levels of MItf and melanogenic enzymes, but no change in overall pigment levels, and no visible pigment phenotype, PMID: 35649693 | Cell-based phenotype; KD increases pigmentation and expression of Mitf and melanogenic enzymes, PMID: 35649693 | |||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Eye decreased pigmentation; head iridophore decreased amount; head melanocyte decreased pigmentation; melanocyte melanosome aggregated, abnormal; melanophore stripe melanosome morphology, abnormal | |||||||
|
|
|
Integument pigment granule sparse, abnormal; iridophore decreased amount; melanocyte decreased amount; trunk decreased pigmentation | |||||||
|
|
|
Diluted coat color, abnormal eye pigmentation, abnormal melanosome morphology, hypopigmentation, buff (bf) | |||||||
|
|
|
Integument melanocyte colorless; retinal pigmented epithelium melanocyte colorless | |||||||
WASHC1 | Washc1 | wash1 | WASH complex (including WASHC1) contributes to the generation of tubular carriers from pigmented melanosomes. KD causes increased melanin production in pigment cells and suboptimal melanin transfer in a human coculture system. PMID: 29875258 | |||||||
|
|
|
Pigment cell quality, abnormal | |||||||
|
|
|
Whole organism decreased pigmentation | |||||||
|
|
|
Cell-based phenotype; increases pigmentation in human melanocytes in culture; also causes increased pigmentation in organ cultured human skin, PMID: 22951732, PMID: 24131586 | |||||||
|
|
|
Cell-based phenotype; KD blocks melanosome maturation; coordinates melanogenic gene transcription and melanosome formation via TORC1 inhibition, PMID: 21317285 | |||||||
|
|
|
PMID: 9353119, PMID: 10963668, Neural crest defects; mouse embryos deficient for both Wnt1 and Wnt3a have a marked deficiency in trunk neural crest derivatives including NC-Ms; also Wnt1 shown to regulate melanocyte development by neural crest lineage gene targeting | |||||||
|
|
|
PMID: 9353119, PMID: 22710324, PMID: 22465131, neural crest defects; mouse embryos deficient for both Wnt1 and Wnt3a have a marked deficiency in trunk neural crest derivatives including NC-Ms; also shown to promote melanogenesis | |||||||
|
|
Abnormal skin appearance, "black bumps are found on the skin of the upper surface of the paws," two independent mouse lines with similar phenotype, also cellular phenotype, PMID: 20589917, PMID: 25705850 | ||||||||
|
|
|
Dyskeratosis congenita DKCB3
(#613988) |
Reticulated skin hyperpigmentation | ||||||
|
|
|
Werner Syndrome
(#277700) |
PMID: 29146545, hypopigmentation; premature hair graying | ||||||
|
|
|
Xeroderma pigmentosum XPA
(#278700) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
Xeroderma pigmentosum XPC
(#278720) |
Pigmented or depigmented macules and patches | ||||||
|
|
|
Belly spot, 14-3-3εfl/fl/14-3-3ζ−/−/Wnt1-Cre+ (conditional); conditional KO of Ywhae causes white spotting, larger spots in ko along with Ywhaz, PMID: 27001213 | |||||||
|
|
|
Belly spot; 14-3-3εfl/fl/14-3-3ζ−/−/ Wnt1-Cre+ (conditional); conditional KO of Ywhae causes white spotting, larger spots in ko along with Ywhaz, PMID: 27001213 | |||||||
|
|
|
Gray hair, melanocyte-specific KO, Yy1f/f; Tyr-Cre (conditional), visible soon after birth, loss of melanocyte development, PMID: 22570637 | |||||||
|
|
|
Skin morphology alterations; Darkened coat color, hyperkeratosis, abnormal epidermal morphology, focal areas in dermis and subcutis around hair follicles with high melanin content, Zbtb17tm1Cksn/ Zbtb17tm1Cksn; Krt14tm1(cre)Wbm/Krt14+ | |||||||
|
|
|
Hair follicle alterations; Abnormal hair shaft melanin granule morphology, clumps of pigment appear to be the remains of degenerating follicles, depilated | |||||||
|
|
Hypopigmentation, developmental loss of hair pigmentation, Zeb2fl/fl; Tyr::Cre (conditional), a.k.a. Zfhx1b; PMID: 24769727 | ||||||||
|
|
Belly spot, kumba (Ku) | zic2a = melanoblast aggregated, abnormal; melanocyte migration decreased process quality; xanthophore differentiation decreased process quality / zic2b = melanoblast aggregated, abnormal; melanocyte migration decreased process quality; xanthophore differentiation decreased process quality | |||||||
|
|
|
Mandibuloacral dysplasia with type B lipodystrophy
(#608612) |
Mottled hyperpigmentation |
Note: The previous Color Genes table (updated till 2011) is still available here.
This WEB page is maintained by Lluis Montoliu (CNB-CSIC, Madrid, Spain)